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Executive Summary 
Background  
Globally, it is estimated that over 200 million women and girls have undergone FGM/C and are 
living with its consequences. In Africa, it is estimated that 27 million, 24 million, and 20 million 
girls and women have undergone FGM/C in Egypt, Ethiopia, and Nigeria respectively, making 
them the countries with the highest absolute numbers of women and girls living with FGM/C in 
the continent. FGM/C practise has no known medical benefit, but it results in mild to severe 
health (physical and psychological) complications as well as social consequences. The health 
complications can be immediate, short-, or long-term. The complications include, but are not 
limited to bleeding, infections, keloid, clitoridal cysts and psychosexual complications. In addition 
to these complications, FGM/C is considered a violation of the rights of women.  
In 2007, the WHO, UNFPA, and UNICEF issued a joint statement against the practice of FGM/C, 
declaring support for its abandonment. Since then, there have been concerted efforts by different 
stakeholders to facilitate abandonment of FGM/C. For example, in 2008, WHO and other United 
Nations agencies passed a joint resolution titled “Eliminating female genital mutilation: an 
interagency statement.’. Global and national efforts have also included the development of legal 
and policy frameworks addressing management and prevention of FGM/C, signing international 
conventions, charters, and agreement such as the Convention on the Elimination of all Forms of 
Discrimination Against Women (CEDAW) in 1979, Convention on the Rights of the Child (CRC) 
in 1989, and the Sustainable Development Goals (SDGs).  
Nigeria has made considerable efforts towards the eradication of FGM/C. These include 
constituting a National Technical Working Group on harmful traditional practices, conducting 
research studies and generating evidence, and drawing up a National Policy and Plan of Action 
(NPPA) for the elimination of FGM/C in Nigeria. The first policy in 2008 was not fully 
implemented and was replaced by a revised version spanning 2013–17 and adopted by the 
National Council on Health. In 2015, as part of a legislative framework to eliminate FGM/C, the 
National Assembly passed the Violence Against Persons and Prohibition (VAPP) Act, which 
criminalises the practice. Beyond this, Nigeria is a signatory to treaties which prohibit harmful 
traditional practices including FGM/C, such as: CEDAW, Protocol to the African Charter on 
Human and People’s Rights on the Rights of Women in Africa (Maputo Protocol); Convention on 
the Rights of the Child; and the African Charter on Human and People’s Rights. 
Like any other health-related issue, the health system is meant to address resulting 
complications of FGM/C and offer prevention strategies. Despite the existence of laws, policies, 
and plans of action that should drive the health system’s response, the practice persists at a 
substantial level in Nigeria. The extent of preparedness of the health system for prevention and 
management of complications is unclear and is yet to be documented. The goal of this study was 
to contribute to a reduction in the prevalence and ultimately the abandonment of FGM/C through 
a diagnostic assessment of the health sector’s response to FGM/C management and prevention 
in Nigeria and the identification of possible solutions for strengthening the existing response. The 
study explored how the health system implements the national policy and plan of action for 
FGM/C, and how the healthcare sector supports the prevention and management of FGM/C-
related complications to identify possible solutions for system strengthening.  
Methodology 
This study utilised a qualitative approach as well as a health facility assessment to understand 
the health system’s response to management and prevention of FGM/C in Imo State. Data-
gathering approaches, including in-depth interviews, focus group discussions, clinical meetings 
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among health service providers, key informant interviews, and stakeholder dialogues (national 
and state level), were used. A health facility assessment was also conducted to examine service 
delivery levels at health facilities. Descriptive statistics were used to summarise health facility 
assessment and qualitative interviews were digitally recorded, transcribed and analysed using 
NVIVO 12 software. Thematic analysis was used to explore emergent patterns and themes 
within the qualitative data. Ethical approval was obtained from Imo State Ministry of Health and 
from the Population Council’s Institutional Review Board.  
Findings 
Findings from this study showed that the policy-development and implementation process at the 
national and state levels were plagued by poor participation of the relevant health system 
stakeholders due to limited funding and poor coordination. The lack of funds to drive activities in 
Imo State led to inadequate planning, supervision, and coordination of FGM/C activities in the 
state. Lack of political will and commitment from government at both federal and state levels for 
FGM/C programmes also hindered policy implementation. The level of readiness of the health 
facilities to handle FGM/C-related complications was low, as evidenced by poor infrastructure, 
lack of equipment, and limited human capacity. Study findings also showed that patients with 
complications of FGM/C present late and logistic/infrastructural challenges hinder effective 
referral. There were no guidelines or protocols for the management of FGM/C at any levels in the 
state and FGM/C documentation at facility-level was almost non-existent. 
Conclusion 
The low priority placed on FGM/C by the government affected policy development and 
implementation. The health system's response to prevention and management of complications 
was suboptimal. The findings from this study suggest that improving the health system response 
in the prevention and management of FGM/C complications requires government ownership at 
all tiers.  
Implications for policy/programmes/research 
Poor dissemination of policies and engagement of state stakeholders has implications for 
stakeholders’ participation in the implementation process. The government should demonstrate 
greater financial commitment and ensure transition and ownership of activities beyond the tenure 
of FGM/C projects. Health workers should be properly trained and sensitised on the WHO 
guidelines on management of FGM/C complications to improve their capacity to respond to 
incidents. The availability of data for decision-making on FGM/C is critical, and gaps in data 
management must be addressed by education and improved data-management systems. 
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Introduction  
Background 
Globally, over 200 million women are cut and living with female genital mutilation/cutting 
(FGM/C) (UNICEF 2016), while 3 million girls are at risk of undergoing cutting each year 
(UNICEF 2016, UNICEF 2014). The World Health Organization defines FGM/C as any procedure 
that involves partial or total removal of the female external genitalia or other injuries to the female 
genital organs for nonmedical reasons (WHO 2008, Rymer 2003). Based on the anatomical 
extent of the procedure, WHO broadly classifies FGM/C into four main types, namely: Type I, 
partial or total removal of the clitoris and/or the prepuce (clitoridectomy); Type II, partial or total 
removal of the clitoris and the labia minora, with or without excision of the labia majora (excision); 
Type III, narrowing of the vaginal orifice with creation of a covering seal by cutting and 
appositioning the labia minora and/or the labia majora, with or without excision of the clitoris 
(infibulation); and Type IV, all other harmful procedures to the female genitalia for nonmedical 
purposes, including pricking, piercing, incising, scraping, and cauterisation (WHO 2008).  
The magnitude of FGM/C is disproportionally spread across different ethnic groups in 30 African 
countries (mainly in East, North East, and West Africa), with pockets in Asia, the Middle East, 
Latin America, as well as North America, Europe, Australia, and New Zealand among migrant 
populations (UNICEF 2016, UNICEF 2014, Yoder, Wang, and Johansen 2013). In Africa, it is 
estimated that 27 million, 24 million and 20 million girls and women have undergone FGM/C in 
Egypt, Ethiopia, and Nigeria respectively, making them the countries with the highest absolute 
numbers of women and girls living with FGM/C in the continent (UNICEF and Gupta 2013).  
In Nigeria, although the practice is considered widespread, national surveys suggest a gradual 
decline of FGM/C prevalence among women aged 15–49 years from 30% in 2008 to 20% in 
2018 (NPC and ICF 2019). Comparison between NDHS 2013 and NDHS 2018 suggests 
reductions across four regions: South East (49% to 35%), South West (47.5% to 30%), South-
South (25.8% to 17.7%), and North West (20.7% to 20.2%). In contrast, the prevalence remained 
the same in the North Central (9.9%) and increased in the North East (2.9% to 6.1%) (NPC and 
ICF 2014; NPC and ICF 2019). The most recent Multiple Indicator Cluster Survey (MICS) in 
Nigeria puts the prevalence of FGM/C at 18%, however, the prevalence in some states is still as 
high as 67% (NBS and UNICEF 2017).  
The prevalence and practises of FGM/C in Nigeria vary across regional and ethnic divides as 
they are driven by social norms and cultural practices. According to the NDHS 2018, the South 
East and North East regions have the highest (35%) and lowest (6.1%) prevalence respectively. 
The state-level prevalence report reflects this, as Imo, Ekiti, Ebonyi, and Osun States (all in the 
southern part of the country) reported the highest prevalence by state (62%, 58%, 53%, and 
45.9%), respectively. Even though the South East region, which has the highest population of 
Igbos, has the highest prevalence by region, the Yorubas have the highest prevalence (35%) by 
ethnic group, followed by the Igbos (31%) and Hausas (20%) (NPC and ICF 2019). FGM/C is 
regarded as a rite of passage into womanhood in some cultures or intended to prevent girls from 
promiscuity (Awusi 2009; Ofor and Ofole 2015). In Nigeria, FGM/C is most likely to take place 
during childhood (NPC and ICF 2014).  
FGM/C has no health benefits. It has, however, undesirable consequences for human rights as 
well as health (physical, psychological, sexual, maternal and child health), and social 
consequences (WHO Study Group et al. 2006, Vloeberghs et al. 2012, Chibber, El-Saleh, and El 
Harmi 2011, Kimani et al. 2016). The health effects associated with the FGM/C can be 
immediate/short and/or long-term (Berg et al. 2014, Kaplan et al. 2011, Morison et al. 2001, 
WHO 2000, 2008; WHO Study Group et al. 2006). The short-term complications are pain, 
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excessive bleeding, swelling, problems with wound healing, and urine retention (Berg et al. 
2014). Genital scarring, menstrual difficulties, urinary symptoms, obstetric complications, painful 
intercourse, formation of cysts, and psychosexual effects are all classified as long-term 
consequences (Dare et al. 2004; Elnashar and Abdelhady 2007; Knight et al. 1999; Njue and 
Askew 2004). Psychological consequences like anxiety, depression, post-traumatic stress 
disorder, and low self-esteem have also been reported among women exposed to FGM/C 
(Whitehorn, Ayorinde, and Maingay 2002; Behrendt and Moritz 2005). Some of the health 
complications are directly related to the extent of the cutting, the poor anatomical knowledge of 
providers, as well as the use of crude and non-sterilised instruments. The majority of women and 
girls living with FGM/C suffer complications that require medical interventions to correct or 
mitigate health risks (WHO Study Group et al. 2006, WHO 2016b). 
Global response to end FGM/C 
In 2007, the WHO alongside UNFPA and UNICEF issued a joint statement against the practice 
of FGM/C, declaring support for its abandonment. Since then, there have been concerted efforts 
by different stakeholders to promote the abandonment of the practice. These include research to 
generate evidence to inform interventions, advocacy, and change in public policy. In 2008, WHO, 
alongside nine UN agencies, passed a joint resolution entitled: “Eliminating female genital 
mutilation: an interagency statement” (WHO 2008). Because of the pervasive nature of the 
problem and the role of health workers in FGM/C, WHO with other international partners 
published a global strategy to stop healthcare providers from performing FGM/C (WHO 2010). 
This was in addition to the adoption of the Millennium Development Goals (MDG) by 191 
countries as a global development agenda. Of the eight MDGs, six were directly related to the 
eradication of FGM/C (28TooMany 2016). At the expiration of the MDGs in 2015, the Sustainable 
Development Goals (SDGs) became the overriding development agenda globally. The SDGs 
make explicit reference to elimination of FGM/C under Goal 5.3—Eliminate all harmful practices, 
such as child, early and forced marriage and female genital mutilation (WHO 2015). 
Global efforts have also included the development of legal and policy frameworks addressing the 
management and prevention of FGM/C. Twenty-six African and Middle Eastern countries, as well 
as 33 countries with practising migrant populations, have adopted laws criminalising the practice 
(UNICEF 2016). In addition, to operationalise the management and prevention of FGM/C, in 
2016 WHO developed guidelines on the management of health complications from FGM/C 
(WHO 2016). Other global efforts to promote abandonment include the creation in 2007 of the 
UNFPA-UNICEF Joint Programme (UNJP) "Female Genital Mutilation/Cutting [FGM/C): 
Accelerating Change” that aimed to protect women and girls by accelerating the abandonment of 
the practice and enhancing care for those living with FGM/C. So far, the UNJP is one of the 
largest interventions to promote abandonment. It works to provide appropriate and quality 
services (3.2 million girls in 17 countries have benefitted from its protection and care); better 
community-led engagement, involving education, dialogue, and consensus-building; legal and 
policy frameworks, including training and enforcement (FGM/C has been banned in 13 countries 
with the support of the programme); government ownership (17 countries supported by the 
programme have a leadership/coordination mechanism and 12 of them established budget lines 
targeted at services to eradicate FGM/C). The programme, currently in the third phase integrates 
complementary interventions to end and eradicate FGM/C and other harmful practices by 2030, 
in line with the SDG agenda (UNFPA-UNICEF 2019).  
FGM/C response in Nigeria 
In addition to signing to several international conventions, charters, and agreement such as the 
Convention on the Elimination of all Forms of Discrimination Against Women (CEDAW) of 1979, 
Convention on the Rights of the Child (CRC) of 1989, MDGs of 2000, and SDGs of 2015, Nigeria 
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has made considerable efforts towards the eradication of FGM/C. These include constituting a 
National Technical Working Group on harmful traditional practices, conducting research studies 
and generating evidence, and drawing a National Policy and Plan of Action (NPPA) for the 
elimination of FGM/C in Nigeria. The first policy in 2008 was not fully implemented and was 
replaced by a revised version spanning 2013–17 and adopted by the National Council on Health. 
The revised version outlines the response from government and civil society organisations 
(CSOs) to include community-level education on the need to eliminate FGM/C, capacity-building 
of stakeholders to sensitise them on negative impact of the practice, advocacy for legislation and 
treatment of FGM/C complications, intersectoral collaboration and integration of anti-FGM/C 
programmes in relevant sectors, and anti-FGM/C legislation at state levels (FMOH 2013).  
In 2015, as part of a legislative framework to eliminate FGM/C, the National Assembly passed 
the Violence Against Persons and Prohibition (VAPP) Act, which criminalises the practice 
(Goldberg 2015). Section 6(1) of the VAPP Act states, ‘The circumcision or genital mutilation of 
the girl child or woman is hereby prohibited’ (Onyemelukwe 2016). The VAPP Act only applies to 
the Federal Capital Territory and is yet to be domesticated in many states (28TooMany 2016). 
However, some of these individual states (about 13 states) including the Federal Capital Territory 
have other law provisions that prohibit the practice. In addition to the CEDAW and VAPP Act, 
Nigeria also signed other treaties which prohibit harmful traditional practices including FGM/C, 
such as: the Protocol to the African Charter on Human and People’s Rights on the Rights of 
Women in Africa (Maputo Protocol) which was adopted in 2003, but ratified by the Nigerian 
government in 2004; Convention on the Rights of the Child, which was adopted in 1989 and 
ratified in 1991; and the African Charter on Human and People’s Rights, which was adopted in 
1981 and ratified in 1983. However, signing a treaty is not enough; such treaties are expected to 
be enshrined in the legal frameworks of the country for them to be fully effective. Thus, a major 
challenge has been the non-domestication of these treaties by the national and state legislatures. 
For instance, the Child Rights Act which also prohibits FGM/C since its adoption in 2003, has 
only been domesticated in 24 states as of 2019 (World Bank 2019).  
Health system’s response to FGM/C 
The health system’s response to FGM/C is achieved through the provision of care (management) 
to survivors and is also expected to play a significant role in prevention through i) communicating 
the risks and health consequences; and ii) supporting policy implementation for the 
abandonment of FGM/C by communities and families, which includes not providing medicalised 
FGM/C and fulfilling legal requirements for reporting cases of FGM/C to the authorities. In 
Nigeria, the existing laws do not explicitly require health workers to report incidents of FGM/C. 
There are limited policy documents and guidelines specific to the prevention and management of 
FGM/C in Nigeria. The NPPA sets targets and outlines strategies for relevant agencies (FMOH, 
2013). The targets include: increasing the number of healthcare facilities that provide care, 
counselling, and support to FGM/C survivors; eradicating medicalisation of FGM/C; identifying 
appropriate indicators and developing relevant data-collection tools on FGM/C elimination for 
integration into the National Health Management Information Systems; and mainstreaming 
FGM/C issues into the national agenda through incorporation into the National Strategic Health 
Development Plan. In addition, the policy implementation strategy includes:  
• integrating FGM/C into sexual and reproductive health /HIV services;  
• advocacy for the integration of FGM/C module into the curricula of health training institutions;  
• sensitising regulatory bodies and health professional associations on the medicalisation of 
FGM/C and penalties for the practice; and 
• supporting regulatory authorities to monitor FGM/C practises in the health sector 
 4 
 
Rationale 
Despite the existence of laws, policies, and guidelines that should drive the health system’s 
response to FGM/C, the practice persists at substantial levels in Nigeria. The progress made in 
creating an enabling environment for FGM/C elimination cannot be sustained without an effective 
response from the custodians of the Nigerian health system.  
As part of the health system response to FGM/C, the extent of preparedness of health facilities 
(primary, secondary and tertiary) to prevent and manage complications of FGM/C is poorly 
understood and yet to be documented. It is also uncertain whether the health sector in Nigeria 
has the capacity to implement FGM/C prevention and management activities. This study seeks to 
address gaps in knowledge through a diagnostic assessment of the health sector’s response to 
FGM/C management and prevention in Nigeria. 
Theoretical underpinning 
Policy analysis framework 
To better understand the Nigerian health system’s response to the prevention and management 
of FGM/C, this study examined FGM/C-related policies using Walt and Gilson’s policy triangle 
model (1994) as a framework to understand the policy implementation processes. According to 
the framework, effective policy analysis requires examining the content of policies, the role of 
stakeholders and how both interact to influence policy, the processes through which the influence 
emerges (i.e., in formulating and implementing policy), and the context in which the different 
stakeholders and processes interact. The framework was applied to analyse and understand 
existing FGM/C-related policies in terms of the content, different policy stakeholders, and 
process (of formulating policy) alongside contextual stakeholders (social, political, economic) to 
determine the health system’s implementation of FGM/C prevention and management services.  
Situation analysis framework 
The situation analysis framework was used to assess the health system’s response to FGM/C 
complications and the quality of care offered to women and girls (Miller et al. 1997). As noted by 
Miller et al, the situation analysis framework is informed by the systems approach for Primary 
Health Care Operating Research (PRICOR), Frerich’s Rapid Survey Methodology, and Bruce’s 
and Jain’s Quality of Care Framework, current policies and programme standards, the readiness 
of service delivery staff and facilities, the actual quality of service received, and impact of 
services on client satisfaction across service delivery points (SDPs).  
Health systems framework 
To organise the report and discussion of this study, the WHO health systems framework was 
used. The World Health Organization (WHO) in 2007 proposed a framework  describing health 
systems in terms of six core components or “building blocks” and they are as follows: (i) service 
delivery, (ii) health workforce, (iii) health information systems, (iv) access to essential medicines, 
(v) financing, and (vi) leadership/governance (Lazarus and France 2014). In essence, the 
building blocks contribute to the strengthening of health systems in different ways. Components, 
such as leadership/governance and health information systems, provide the basis for the overall 
policy and regulation of all the other health system blocks. Financing and the health workforce 
are components regarded as input to the health system while medical commodities, 
technologies, and service delivery reflect the immediate outputs of the health system. 
 
 5 
 
Figure 1: Study theoretical framework 
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Objectives 
Study goal  
The goal of the study was to contribute to the reduction in the prevalence and ultimately the 
abandonment of FGM/C through a diagnostic assessment of the health sector’s response to 
FGM/C management and prevention in Nigeria and the identification of possible solutions for 
strengthening the existing response. 
Specific objectives 
1. To examine how the healthcare sector supports the prevention of FGM/C; 
2. To determine the role of the health care sector in the management of FGM/C-related 
complications including psychosexual effects and the quality of care offered to clients; 
and 
3. To identify possible solutions for strengthening the healthcare sector towards 
management and prevention of FGM/C. 
Main research questions 
This study seeks to address the following key research questions: 
1. How is the health sector responding to existing FGM/C-related laws and policies? 
2. What role is the healthcare sector playing in the prevention of FGM/C? 
3. How are contextual stakeholders supporting or inhibiting the health sector’s response to 
FGM/C?  
4. What is the availability, content, and quality of FGM/C-related service provision? 
5. How is the health sector catering to the needs of women/girls who have undergone 
FGM/C?  
Methods 
Study design 
This study utilised a qualitative approach as well as a health facility assessment to understand 
the health system's response to management and prevention of FGM/C in Imo State. The study 
was characterised by different data-gathering activities targeting different research participants. 
In all, there were seven data-gathering activities:  
1) Structured consultative multi-stakeholder dialogues at national and state levels;  
2) Key informant interviews (KIIs) with FGM/C policy stakeholders at national and state 
levels to obtain their knowledge and views about the health system’s policy process 
related to FGM/C prevention and management; 
3) Focus group discussions (FGDs) with health service providers to obtain information on 
the implementation of FGM/C prevention and management services;  
4) In-depth interviews (IDI) with health service providers to explore their knowledge, 
attitudes, and practises regarding FGM/C and its management and prevention;  
5) IDIs with clients or parents of clients who have experienced FGM/C-related complications 
and presented at health facilities to explore the quality of care and satisfaction with the 
service delivery process;  
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6) Health facility assessments in selected health facilities in Imo State to assess service 
readiness in terms of staffing and availability of equipment; and 
7) A clinical grand round at a tertiary health institution.  
Due to anticipated difficulty in obtaining robust information about the policy context of FGM/C and 
the health system’s response from conventional data-gathering methods, two structured multi-
stakeholder dialogues were conducted to obtain information and perspectives on the current 
state of the health sector’s response to FGM/C, current FGM/C practise in the State, gaps in the 
health sector’s FGM/C response, and the policy context of FGM/C. The dialogues provided a 
platform for relevant stakeholders to discuss their perspectives based on their experience and 
knowledge about the topic in focus. 
The clinical grand round is a formal meeting during which healthcare professionals 
(doctors/specialists, nurses, social workers, students) discuss clinical cases and recommend 
strategies for improved patient care. The clinical grand round facilitates interaction between 
health workers in a clinical setting (doctors, nurses, social workers). In this study, the grand 
round provided observational data to understand the process of care provided for patients with 
FGM/C complications. Two clinical FGM/C cases were presented at the meeting and followed by 
a structured discussion about diagnosis, standards of care, prevention, and follow-up. The 
discussion was between healthcare providers and moderated by researchers. 
Study site 
The study was conducted at the national level and in Imo State, in the South-East geopolitical 
zone of Nigeria. It was chosen for the study because it has one of the highest prevalence rates of 
FGM/C (68%) (NPC and ICF 2019) (see Figure 2) and 61% of FGM/C is medicalised. (NPC and 
ICF 2014) It is also one of the states where the UNJP is carrying out intervention programmes on 
FGM 
Alhough Nigeria has about 250 ethnic groups, Hausa, Igbo, and Yoruba account for most of the 
population (60.7%) (CIA 2018). Imo State had an estimated population of about 4 million (49.7% 
female) in 2006 when the last census was conducted, and a landmass size of 5,182.8 km2 (NPC 
2009). The Igbo language is spoken throughout the state with slight variations in dialects. 
According to the NDHS 2018, 65% of men and 50% of women had completed secondary school 
and had more than a secondary level of education (NPC and ICF 2019). FGM/C is criminalised in 
Imo State under a provision of the Imo State Child Rights Law 2004 and the Imo State Female 
Genital Mutilation Law 2017.  
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Figure 2: Percentage of women age 15–49 who have undergone FGM/C  
 
 
 
 
Source: NPC and ICF 2019 
Participants 
The study population comprised the following categories of informants: 
• Anti-FGM/C advocates; 
• Representatives of NGOs engaged in FGM/C abandonment interventions; 
• Representatives from governmental bodies (relevant ministries and parastatals) involved in 
health system administration and/or the FGM/C response; 
• Health development partners; 
• Health professional associations; 
• Health professional regulatory organisations and training institutions; 
• Health service providers (doctors, nurse/midwives, and community health workers) working 
in tertiary, secondary, primary, and private health facilities;  
• Health facility administrators of tertiary, secondary, primary, and private service delivery 
points; and 
• Clients – women/girls who have experienced complications of FGM/C and adult men who are 
partners/fathers of women/girls with FGM/C-related complications. 
Sampling technique 
Structured consultative multi-stakeholder dialogues were conducted among a diverse group of 
individuals involved in the FGM/C response and the health sector at national and state levels. 
Participants included government stakeholders, members of health professional boards, 
representatives of health professional associations, health training institutions, nongovernmental 
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organisations (NGOs), and implementing partners working on FGM/C. Additionally, key informant 
interviews were conducted among different stakeholders at both the national and state levels as 
shown in Table 1.  
Focus group discussions (FGDs) were conducted among health service providers comprising the 
three major cadres (medical doctors, nurse/midwives, and community health workers). In-depth 
interviews (IDIs) were also conducted among these participants. Additionally, IDIs were 
conducted among clients who had experienced complications of FGM/C and sought treatment at 
a health facility. The clinical grand round was conducted among diverse healthcare providers at 
the state level. A few of these participants were drawn from the Federal Medical Centre, Owerri 
while the remaining participants were drawn from the Imo State University Teaching Hospital, 
Orlu. The participants covered different cadres of health workers (doctors, nurse/midwives) and 
allied professions (such as social workers) selected from across several medical 
specialties/hospital units that could possibly be involved in the management of women/girls who 
have experienced FGM/C-related complications. 
Selected health facilities were assessed for service readiness in Imo State. These health facilities 
were drawn across the three levels of care; primary, secondary, and tertiary. The facilities 
assessed also included private facilities. The primary health facilities were randomly selected 
across the 10 focus local government areas (LGAs) of the UNJP. The other facilities were 
purposively selected. These facilities were selected because the majority fall within the 10 focus 
LGAs of the UNJP and are also the LGAs with the highest prevalence of FGM/C in the state. The 
facilities that fall outside these LGAs were primarily secondary and tertiary facilities and they 
were chosen because of the small number available. A detailed description of the type and 
number of different participants is summarised in Table 1. 
Selection of research participants 
The selection of participants for the multi-stakeholder dialogues and the key informant interviews 
stemmed from the scoping visit at the state level and initial stakeholder engagement activities at 
the national level. Relevant organisations and governmental departments were mapped. 
Thereafter, the relevant stakeholders were contacted and followed up through different means 
such as letters, phone calls, and text messages.  
For the FGDs and IDIs with health service providers, participants were selected through the 
health professional associations and the Imo State Hospital Management Board (SHMB). The 
nurses and midwives were recruited through the Imo State chapter of the National Association of 
Nigerian Nurses and Midwives while community health workers were recruited through the Imo 
State chapter of the National Association of Community Health Practitioners of Nigeria. The 
doctors were recruited through the SHMB. During the planning stage of the activity, the criteria 
for selection of health workers were sent to the associations and the Board. For the in-depth 
interviews with clients, three participants were drawn from two cases of FGM/C complications. As 
described above, one was a client while the other two were parents of a girl who had suffered 
complications. The parents were recruited through an FGM/C stakeholder in Imo State while the 
first client was recruited through the data-gathering activities that preceded the IDIs with clients.  
 
The selection of health facilities for the HFA was guided by the following; 
1. The UNJP intervention in local government areas; and   
2. The information available on functioning health facilities obtained from the Imo State 
Primary Health Care Development Agency and the State Hospital Management Board. 
According to the information gathered, it was revealed that the state had three tertiary health 
facilities and 11 functional public secondary health facilities also known as general hospitals. Due 
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to the limited number, all 11 functional public secondary facilities were assessed. Two out of 
three tertiary health facilities were assessed. These tertiary facilities were Imo State University 
Teaching Hospital, Orlu, and State Specialist Hospital, Umuguma. At least three primary 
healthcare (PHCs) facilities and one private health facility were selected per UNJP intervention 
LGA. Thirty-eight PHCs were randomly selected from a pool of 195 primary healthcare facilities. 
These facilities were assessed across 14 LGAs of Imo State. 
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Table 1: Overview of the data-gathering activities of the health system study 
 
S/N Data-gathering 
activities 
Study Population Sample size Location of activity Methods Duration 
1 Multi-stakeholder 
dialogue 
Anti-FGM/C advocates, representatives of NGOs 
engaged in FGM/C abandonment interventions, 
governmental bodies involved in health system 
administration and/or the FGM/C response, and 
health professional associations 
32 Federal/national and 
state level, neutral 
setting 
Facilitated structured 
dialogues led by PI 
July 21, 2018 
(State-level 
dialogue);  
 
July 26, 2018 
(National-level 
dialogue) 
2 Key informant 
interview 
Representatives from the government (relevant 
ministries and parastatals), private organisations, 
NGOs, health development partners, health 
professional associations, health professional 
regulatory organisations, and training institutions 
11 Federal/national and 
state level, neutral 
setting 
Face-to-face interview  July–August 2018 
3 Focus group 
discussions with 
health-care workers 
Healthcare workers (doctors, nurse/midwives, 
community health workers) working in tertiary, 
secondary, primary, and private health facilities 
59 (doctors—13; 
community health 
workers—24; 
nurse/midwives 
—22) 
State-level, neutral 
setting  
Focus group discussions 
led by PC research 
assistants 
6–8 September 
2018 
4 In-depth interviews 
with health -care 
workers 
Healthcare workers (doctors, nurse/midwives, 
community health workers) working at selected 
service delivery points 
10 State-level, health 
facility 
Face-to-face interviews 
led by PC trained 
research assistants 
10–14 September 
2018 
5 Health facility 
assessment  
Health facility administrators of tertiary, secondary, 
primary, and private service delivery points  
61 State-level, health 
facility 
Research assistants 
administered facility 
checklist 
November 19– 
December 4, 2018 
6 Clinical grand round Multi-specialty health workers across cadres and 
allied professionals involved in FGM/C care  
84 State-level, health 
facility 
Case presentations & 
discussions by health 
providers 
November 2, 2018 
7 In-depth interview 
with clients 
Clients – girls and women who have experienced 
FGM/C-related complications and received services 
from the health system; parents of girls who have 
experienced FGM/C-related complications and 
received services from the health system  
3 State-level, neutral 
setting 
Face-to-face interviews 
led by PC trained 
research assistants 
 
1–2 February 
2019 
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Instruments  
The health system study component used multiple instruments—guides for the multi-stakeholder 
dialogues, KIIs, FGDs, and IDIs as well as a health facility assessment (HFA) inventory. The 
multi-stakeholder dialogue guides contained questions targeted at assessing general knowledge 
of FGM/C in Nigeria and Imo State, the general response to FGM/C in Nigeria and Imo State, the 
health system’s response to FGM/C including what is currently being done and the key 
stakeholders involved, prevention and management of FGM/C complications, and the 
effectiveness of the health system’s response.  
The KII guide focused on events that triggered agenda-setting on FGM/C, the input of different 
stakeholders in the implementation of health system FGM/C policies, implementation of the 
policy, and the process relating to FGM/C management and prevention strategies emanating 
from the policy. The FGD guide focused on eliciting responses on healthcare providers’ 
experience and training on FGM/C, knowledge of FGM/C prevention/management standards, 
attitudes towards FGM/C practise, attitudes towards implementation of existing FGM/C policies, 
and FGM/C prevention/management practises including referral mechanisms and supervision. 
The guide for IDIs with healthcare providers addressed general attitudes and knowledge on 
FGM/C, management of FGM/C complications, prevention of FGM/C, supervisory mechanisms 
and documentation of FGM/C. The HFA inventory is a 129-question tool comprising nine 
sections designed to garner information on facility operations; provision of services; availability of 
equipment and service commodities; availability of information, education and 
communication materials and activities; supervision; availability of protocols and guidelines; 
referral system related to FGM/C; and staffing. The tool was interviewer-administered with every 
session facilitated by two ield assistants and a supervisor. 
The validity of the guides and inventory was ensured through an extensive literature review to 
identify necessary questions and variables. The draft instruments were reviewed by four 
researchers at the Population Council, pretested, and revised prior to the data gathering 
activities. 
Data collection 
The data-gathering activities for this study started with the multi-stakeholder dialogues held in 
July 2018. This informed the methodology of the other activities as plans were modified 
according to field realities. The KIIs followed the dialogues and these interviews were conducted 
from July to August 2018. After the KIIs, the focus group discussion and in-depth interviews with 
health service providers were conducted consecutively in September 2018. The clinical grand 
round was conducted at the Imo State University Teaching Hospital in November 2018. The 
health facility assessment was conducted from November to December 2018. The last data-
gathering activity for the study was conducted in February 2019. The data-gathering activities 
were conducted in safe, conducive environments with keen consideration for ethical and cultural 
sensitivity. 
Data analysis 
Qualitative data 
All audio recordings and electronic copies of transcripts were stored on password-protected 
computers in folders on a secure network. All hard copies of inventories, checklists, and 
questionnaires were kept under lock and key at the Population Council office in Abuja, Nigeria 
and were only accessible to the members of the research team. The audio recordings were 
transcribed using a transcription protocol developed for the study. The qualitative data-gathering 
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activities addressing similar research questions and similar research participants were analysed 
together.  
The transcribed qualitative data were reviewed by the research team and transferred to NVivo 12 
software to organise the data for analysis. Thematic analysis was used to explore emergent 
themes from the data. Three researchers read the transcripts for initial familiarisation of data and 
codebook development. The codebook was developed using a hybrid approach drawing from the 
elements of the conceptual framework and the emerging themes. The researchers coded the 
same transcripts to ensure that the codes were consistently applied, and discrepancies were 
resolved through a consensus-building approach guided by the research objectives. The final 
themes were used to develop a final thematic framework. 
Quantitative data 
For the health facility assessment data, administered inventories were checked by data collectors 
after each activity. They were further checked for completeness by supervisors of each group 
before being sent to the Population Council Office in Abuja, where forms were rechecked and 
edited for completeness and accuracy by a data analyst. A serial number was appended on each 
copy of the tool for easy identification, and recall of any instrument with problems for correct data 
entry and analysis. A coding guide was also developed after a careful review of responses to 
facilitate coding and data entry. Data were entered with SPSS version 22 and analysed using 
descriptive statistics.  
Ethical considerations 
The study received ethical approvals from the Institutional Review Board of the Population 
Council, the National Health Research Ethics Committee, and the Imo State Ministry of Health. 
Administrative permission was sought from the Imo State Ministry of Gender Affairs and Social 
Development, Imo State Primary Health Care Development Agency, and the Imo State Hospital 
Management Board. Permissions were also sought from health facilities before assessment. 
Steps were taken to minimise risk for facility heads and other interviewees that participated in the 
activity. Information provided by participants was treated with anonymity and confidentiality by 
the study team. This was done by removing personal identifiers from study materials. 
Participants were only required to provide verbal informed consent and, as a result, did not have 
their names and signatures tied to informed consent forms. During the informed consent process, 
the aims of the study andpossible risks were thoroughly explained. Participants were assured of 
their rights, particularly that they could withdraw from the study at any time. They were also 
assured that their responses would not be shared with other parties including regulatory bodies, 
their supervisors or employer, and the police. 
Results 
As previously described, a total of 176 people comprising a wide range of stakeholders, health 
service providers, and clients were engaged in focus group discussions, key informant 
interviews, in-depth interviews, and stakeholder dialogues as shown in Table 1. In addition, 
facility assessments were conducted in 61 health facilities. Findings from the different data-
collection approaches are integrated and discussed in line with the WHO Health Systems 
Framework’s six building blocks: leadership and governance, finance, service readiness, health 
workforce, health information systems, and availability of medicines.       
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Leadership and governance 
FGM/C policy formulation and dissemination at the national level  
There was a consensus among stakeholders that elimination of FGM/C practise in Nigeria 
required multi-sectoral collaboration by governmental and nongovernmental partners to drive 
policy formulation, facilitate policy implementation plans, and create an enabling environment for 
stakeholders. The NPPA and the VAPP Act shaped the implementation of FGM/C activities in 
Nigeria. The government's commitment to develop the policies that will facilitate an enabling 
environment for FGM/C programme implementation was acknowledged. Unfortunately, the 
government had not provided the financial resources needed for implementation.  
“…the government of Nigeria is doing something because FGM eradication is important 
to them.… In the new law of VAPP, in the national policy and plan of action, [there are] 
standards and guidelines for medical management of victims of violence in Nigeria…but 
it is implementation that is the issue,… This is to tell you that it is important for them, but 
the issue now is financial involvement, which is key to get it done ….. we are looking at to 
get it done. Government has not really done anything on that aspect and it’s a 
problem.…”  
—Participant from multi-stakeholder dialogue 
Conversations about the need for a policy agenda for FGM/C in Nigeria dates as far back as 
1998 when a national baseline study on harmful traditional practices affecting women and girls 
was conducted indicating a high prevalence of FGM/C. Stakeholders believed that the policy and 
action plans were shaped by findings from the National Demographic and Health Survey (NDHS) 
that highlighted FGM/C prevalence in Nigeria. The first NPPA developed in 2006 was based on 
the findings from the 2003 NDHS; some stakeholders reported that the plan underestimated the 
level of response needed to facilitate abandonment because the 2003 NDHS underreported 
FGM/C prevalence especially in the North West. The revised 2013 NPPA was a better reflection 
of the FGM/C situation and action needed.  
“The national policy and plan of action was done in 2006, it had a life span.… So, in 
2013, we felt it has already stayed for seven years and it was time for it to be reviewed… 
the first policy did not show this much prevalence, but with the second policy that is the 
reviewed policy, it became obvious that this practice is actually prevalent, but we didn’t 
know about it. Another reason why we reviewed it is also because the Nigerian 
Demographic and Health Survey (NDHS) had painted a picture that the prevalence was 
low, and you know when government sees that it is low, government will not give you 
priority.”  
—Key informant, national policymaker interview 
Participants reported that the policy development process was guided by international 
conventions and contributions from participants at national, state-level, and development 
organisations. National-level participants were aware of the multidisciplinary nature of FGM/C 
issues and noted that different stakeholders participated in the policy formulation process, such 
as NGOs and CSOs, professional organisations such as the Society of Gynaecologists and 
Obstetricians (SOGON), the National Association of Nurses and Midwives (NANM), and the 
Medical and Dental Council (MDCN), as well as government ministries/parastatals. Awareness of 
the FGM/C policy and plan of action at the national level was good as a majority of stakeholders 
were aware of the plans.  
Although the draft NPPA document was presented to regional stakeholders for validation and 
adaptation based on specifics within their region prior to the policy dissemination process, which 
was led by the Federal Ministry of Health (FMOH), some participants felt that state-level 
participants were not involved. One of the key activities of the UNJP was to encourage state 
domestication of VAPP in  Imo State, as well as other high-prevalence states.  
 15 
 
“It was multi-stakeholder, though I cannot say it involved state-level participants. But at 
the federal level, CSOs, governmental organisations, people were involved in the 
development and we had contributions, it was highly participatory, people recognised the 
fact that it is a practice that must end. So, in terms of the length it went to, it did not go 
down to the state level,…” 
—Key Informant, national development actor interview  
Funding issues hindered the capacity of FMOH to visit all the high-prevalence states and there 
was a consensus among participants that the NPPA document was not adequately disseminated 
to state-level stakeholders, resulting in limited awareness of the policy at the state level. The 
limited knowledge of policies at the state level was noted to ultimately affect policy 
implementation. In some high-prevalence states such as Imo State, stakeholders were not aware 
of the FGM/C policy document and no technical committee was constituted to implement the plan 
of action after the guidelines were developed. Some participants reiterated that the state 
stakeholders were not part of the policy formulation.  
“… when I joined this programme in October 2015, I wasn’t even aware of the policy at 
that time, I ran into someone that had the copy so I made photocopies and when I took it 
to the Ministry of Health in Imo State they hadn’t seen the policy, I was the one that gave 
them the first copy of the policy and we have tried to relate with it in terms of doing our 
meeting with the State Technical Committee, which is one of the provisions in the policy 
that every state must have a multi-sectoral committee that will coordinate FGM 
intervention in the state. The state has not drawn its activities from the plan.…In April we 
tried to get the committees to function according to the policy, because the policy there 
are eight responsibilities for the committee, so we try to form subcommittees to unbundle 
those responsibilities and also to use the plan of action… in advocacy to the government 
in terms of funds saying that there is already a policy in place and with resources we can 
actualise what we can so that they won’t be over-dependent on joint programme 
activities.”  
—Key informant, state development actor interview  
State-level operationalisation of FGM/C policies in Imo State 
Participants from Imo State reported on the complications of implementing laws and policies 
related to FGM/C in Imo State:.  
“… I am aware of The Violence Against Person’s Prohibition Act of 2015…In Imo State 
we have the Child Rights Law of 2004 which has a provision on FGM but then we had an 
interesting scenario....We had the VAPP that was passed in 2012, and after one year it 
was repealed because there was an offensive part of that law, "termination of 
pregnancy," so they repealed the entire law on VAPP... But now, there is a bit of a 
confusion because at some point we had the VAPP law which had a provision against 
FGM, we also had the sexual offence bill which was also presented in the House at the 
same time. At the point, both bills got to second reading and then things had to stop and 
then House committee on health decided to go ahead with the Sexual Offence Bill 
because they felt it is weightier to have it as a single offence bill than to have it 
embedded in VAPP. I heard this directly from the head of the legal department of the 
House of Assembly.…”  
—Key informant, state development actor interview 
“one of the gaps is that the existing law is not being implemented, we know that Imo 
State has passed this law on female genital mutilation for over 10 years now and I don’t 
know of any arrest.…I think that the political will to implement these laws [is] not there.”  
—Participant from state multi-stakeholder dialogue 
Despite these legal frameworks in place in Imo State, participants opined that policy 
implementation in the state was poor, and no offender had been convicted since the laws were 
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enacted. A national-level participant corroborated this point by stating that in the states that had 
domesticated the VAPP Act, the implementation was ineffective.  
The State Technical Working Committee for FGM/C in Imo State was reported to be non-
functional due to inadequate personnel dedicated to FGM/C programmes. Meetings were 
irregular, coordination was poor and focal staff for FGM/C lacked office space. The State Ministry 
of Health, which was charged with the responsibility of policy implementation was limited by 
resources and the government lacked the political will to prosecute offenders. In addition, 
stakeholders believed that the government (both Federal and State) placed a low priority on 
FGM/C programmes compared to other healthcare programmes and public health issue such as 
HIV/AIDS and Ebola that required an urgent and structured response.  
“FGM in Imo State has not been viewed in terms of an emergency that needs that kind of 
response, like we have some AIDS victims, we know where we direct them to….but as 
regards FGM, everything that is being done now is either in theory, in policy formulation.” 
—Participant from multi-stakeholder dialogue 
“…in terms of how FGM rests on the issue of public health, I would like to say that it is 
not really something that is considered as a burning issue presently. As a member of the 
Association of Public Health Physicians of Nigeria, I will say in the last five scientific 
conferences we had, not even a single paper has [discussed] FGM. Things like universal 
health coverage, regulated tropical diseases are considered the burning issues.” 
—Participant from multi-stakeholder dialogue  
 
Challenges with policy formulation, dissemination, and domestication  
Funding challenges limited the participation of relevant state stakeholders during the policy 
formulation process. Many participants at the national level asserted that the limited involvement 
of states and relevant ministries during the policy formulation and dissemination process 
adversely affected the policy implementation process. Poor dissemination of the policy by the 
FMOH resulted in little or no awareness of the existing policies and poor communication between 
ministries, departments and agencies also meant that they did not understand the linkages and 
synergies required for policy implementation. This ultimately impacted the sensitisation of CSOs 
working on advocacy and, consequently, the public. Finally, the state activities were not driven by 
activities described in the policy and action plan because of a lack of awareness.  
“Because you have a plan of action, plan of action comes with funding anyway, so if the 
funding is not there it limits what you can do in terms of implementation. So, even if there 
are relevant personnel who by the way are not enough. Even if they are there and there 
is no allocation of funds to support the implementation, it's still a gap.”  
Participant from national multi-stakeholder dialogue 
In Imo State, the Ministries of Gender Affairs and Health had shared responsibilities for 
coordinating the activities in the policy and action plan. There were, however, issues with 
coordination of meetings between these ministries. Other relevant health system stakeholders 
such as the State Primary Health Development Care Agency (SPHCDA) and Department of 
Planning, Research and Statistics (DPRS) were not properly engaged in policy implementation, 
resulting in poor collaboration between health system and FGM/C response organisations such 
as NGOs, CSOs, the health professional associations, and regulatory bodies. This consequently 
led to a suboptimal response for prevention and management of FGM/C.  
“The other problem that I see is that the policy says that Ministry of Health is the 
convener and Ministry of Women Affairs is the co-convener, so depending on the state 
and who has the resources to organise the meetings. There have been power dynamics 
in terms of holding those meetings and then implementing the resolutions. If you look at 
the 20 statutory people listed on that committee, six of them come from Ministry of Health 
showing clearly that this sector contributes more.… So, if you look at all the people who 
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are involved, they are those who are responsible for generating the report from that 
sector and implementing the programme, but it hasn’t really worked out that way.…”  
—Key informant, state development actor interview 
“… the professional associations are not really doing the work they are supposed to be 
doing.... How many of their members understand these issues as real health challenges? 
It is an issue, be it National Association of Community Health Practitioners, be it the 
nurses, and be it NMA. Are they addressing these issues from such a perspective that 
they want to assist government?”  
—Participant from national multi-stakeholder dialogue 
In addition to the funding from the UNJP for FGM/C programmes in Nigeria, the government’s 
funding commitment was also noted to be important for the ownership and sustainability of 
programmes. Some participants noted that the paucity of funds at the federal and state levels 
resulted from delays in budget approval and slashing of budgets at the approval stage. At 
national/state level, government’s commitment was low because FGM/C was not a priority.  
These issues resulted in low motivation of health workers, poor engagement of relevant 
stakeholders such as health professional associations and private health facilities. Private health 
facilities were considered important stakeholders because a large proportion of women visit 
them, and staff capacity was low because they did regularly receive formal training, some were 
not licensed/registered, and possibly they did not possess a sound knowledge of FGM/C and its 
consequences.  
Finance 
Budgeting and funding for FGM/C activities 
There was consensus among participants that most of the funding for prevention activities for the 
ministries, departments, and agencies was from development partners and international NGOs 
resulting in funded activities centred on donor priorities. Although the government expressed 
interest in addressing FGM/C, this interest was not backed by financial investments in advocacy 
and programme or policy implementation. Some stakeholders pointed out that domiciling FGM/C 
in the gender department as opposed to the reproductive health unit as in the case of 
vesicovaginal fistula (VVF) affected funding and commitment to FGM/C. Some state 
stakeholders reported using personal funds to implement the FGM/C activities.  
“… UNFPA has been wonderful in terms of support. If not UNFPA and UNICEF, for us as 
Federal Ministry of Women Affairs, we would have been doing nothing as far as FGM is 
concerned and I think one of the big gaps at government level is the issue of budget. It’s 
one thing to budget for FGM, it’s another thing for the budget to get approved by the 
national assembly….”  
—Participant from national multi-stakeholder dialogue 
 
“The response is always the lack of funds, even to set up technical working groups, the 
policy provides that technical working groups, and national advisory or state advisory 
groups hold meetings for such things to be established, that they are not encouraged, the 
states are not even thinking in that direction. So, it’s always been that we will provide the 
policy, provide the guidelines, but the money has to be spent by the state and most times 
they just tell you that [there are] no resources...”  
—Key informant, national policymaker interview  
The FGM/C activities were limited to UNJP focal states and selected communities; participants 
expressed concerns that FGM/C activities did not cover communities outside UNJP coverage. To 
mitigate the challenge of funding multiple programmes, some stakeholders recommended the 
integration of FGM/C services into existing programmes such as reproductive health. The future 
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sustainability of FGM/C programmes was also discussed as well as the need for the federal and 
state governments to take ownership.  
“Whatever we are doing in the Federal Ministry of Health is under donor support. Outside 
donor support, no kobo [money], nothing from the government that is motivating the work 
on FGM. My own observation that is supposed to be integrated into reproductive health 
and not standing alone.…” 
—Participant from national multi-stakeholder dialogue  
“You know they [international donors] can’t be there for life for us. That’s why the issue of 
ownership is key. We just have to see it as our project. At least for now it is a bit stable, 
you know they themselves are gathering money from donors.…” 
—Key informant, national NGO interview 
Service readiness  
Services provision 
There were two categories of services that were provided by the health system and FGM/C 
programme implementers—community-based services and health-based interventions.  
Community-based services 
Community-based services ranged from community dialogues, sensitisation of community 
leaders, training of FGM/C champions, school sensitisation, and social media advocacy to 
provision of alternative income for cutters as shown in Table 2. Innovative ways of reaching 
community members in Imo State included church meetings, and women’s programmes, as 
platforms to gather all community-level stakeholders in the state—especially the influencers of 
FGM/C such as mothers-in-law, women leaders, and elders—to sensitise them on FGM/C and 
its effects. Champions were also trained to do house-to-house advocacy in states with high 
prevalence rates of FGM/C. The capacity of community-based teams to provide services to 
communities was limited by logistic issues that made it difficult to gain access to remote areas. 
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Table 2: Service provision (FGM/C activities led by health and FGM/C stakeholders) 
Community-based activities 
Community dialogue 
and sensitisation 
 
[Among] The traditional rulers, after having a meeting with them and telling them the 
dangers involved and the number of people dying as a result of mutilation, during the 
training we found out that some of them are also… experiencing such problems, they 
cannot fully have marital sex because of the danger of mutilation. It is through our 
sensitisation and dialogue that they started knowing what it is.… So, they started 
restricting, there was even a time most of the communities started coming up for 
declaration and they have their certificate. —Key informant, state policymaker interview  
 
Training of Champions You know we have trained some of the champions who monitor the women when they are 
pregnant, follow them until they deliver, follow the child until the child is up to 2 months. 
We trained them, they will go to their Eze and do advocacy....They will be going house to 
house and also finding those that are mutilated and those who are not mutilated. Those 
that are pregnant, up to their delivery they monitor these people and give us feedback. —
Key informant, state policymaker interview  
 
Social media advocacy We are really engaging the youth. We realised that the youth of nowadays if you want to 
catch them, use social media. So, we have a social media advocacy group, on Instagram, 
everywhere and then every Thursday there is a Twitter conference between 5 and 7 pm. 
There is also a frown challenge, [where] we frown at FGM. It is part of the advocacy to 
end it. And next week the topic is, “what are the roles of students/youth in FGM 
eradication”, to ensure that people come together and discuss it.… —Participant from 
state multi-stakeholder dialogue  
 
School sensitisation …the main programme we did then was school sensitisation on FGM. The programme 
was grouped into three but was mainly about sensitising the schoolchildren about FGM 
and making sure they actively participate… but some of them were not within our direct 
programme…We visited about seven schools, but it was mainly in the areas with the high 
prevalence rate.… That was my first time having direct contact with FGM. —Key 
informant, state policymaker interview  
 
Training and provision 
of alternative income-
generation for cutters 
This quarter we planned for an alternative source of livelihood (for traditional cutters). 
When we are stopping them from taking ₦2000 for a child, to “not cut again,” we then 
gave them ₦10,000 to start another business, when we are not there they will always go 
back to the table and start cutting. —Key informant, state policymaker interview  
Health-based interventions 
Health workers training 
on prevention and 
management of 
complications 
We've carried out interventions that are targeting state ministries of health providing them 
with [information about] what FGM is, the types that are [practised] and what could be 
done for those who have been mutilated, and we’ve also provided the information on how 
it could be prevented by way of discouraging doctors who may wish to do that, whether in 
government facilities or outside government facilities, providing them information on the 
dangers of FGM. —Key informant, national policymaker interview  
 
Inclusion of FGM/C 
topics in the curriculum 
of health professional 
school  
 
This has always been enshrined in our curriculum. From the training of junior CHEWs 
(community health extension workers) to the senior CHEWs and to the community health 
officers, the senior cadre of them. This has always been a robust part of their curriculum 
and when we do our ANC in the primary healthcare centre, FGM teaching forms the bulk 
of the health education delivered to mothers when they come to antenatal clinics.  —
Participant from national multi-stakeholder dialogue 
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Results from the Health Facility Assessment (HFA) 
Services provided at the facility level 
It is necessary to understand the scope of services provided at the different levels of care to 
better describe the performance of the health system as a whole in addressing FGM/C as well as 
service readiness. Services pertaining to FGM/C include sexual and reproductive health services 
as well as psychosexual services. The services assessed are those that would indicate the 
capacity of the health facility to respond to the possible cases of FGM/C complications.   
 
The provision of services per facility is highlighted in Table 3. Most PHCs provided services on 
HIV testing (92.1%), HIV counselling (92.1%), family planning (81.6%), antenatal care (97.4%), 
childbirth and delivery (94.7%), postpartum care (92.1%), essential newborn care (97.4%), child 
immunisation (100%), child growth monitoring (89.5%), and emergency outpatient care (94.7%). 
Specific FGM/C management services were provided by 63.2% of PHCs. In contrast, fewer 
PHCs provided the following services: screening and treatment of sexually transmitted infections 
(STIs)  (28.9%), HIV treatment and care (7.9%), prevention of mother-to-child transmission 
(15.8%), assisted vaginal delivery (13.2%), and psychological/psychiatric services (21.1%).  
For secondary/tertiary health facilities, all provided services on HIV testing, HIV counselling, 
antenatal care, and emergency outpatient care. Most provided services on screening and 
treatment STIs (95.7%), family planning (87%), infertility consultation (82.6%), pelvic exams 
(95.7%), childbirth/delivery (95.7%), postpartum care (91.3%), post-abortion care (95.7%), and 
sexual and gender-based violence treatment and counselling (91.3%). The proportion of 
secondary/tertiary facilities that provided specific FGM/C services was 69.6%. Only 39.1% 
provided psychological/psychiatric services. 
Most health facilities had general protocols and guidelines, but none had a protocol on FGM/C. 
Of the types of protocols and guidelines available, more (31.6%) health facilities had the basic 
guide on immunisation for health service providers in Nigeria. Protocols and guidelines were 
used at 79.6% of assessed health facilities 
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Table 3: Provision of services from the Health Facility Assessment (HFA) 
% of services provided per facility  PHC (n=38)  Secondary/tertiary (n=23) 
 (n) Percent  (n) Percent 
Screening and treatment of sexually transmitted infections  11  28.9  22  95.7 
HIV testing   35  92.1  23  100 
HIV counselling   35  92.1  23  100 
HIV treatment and care  3  7.9  13  56.5 
Prevention of mother-to-child transmission  6  15.8  13  56.5 
Family planning   31  81.6  20  87.0 
Infertility consultation  17  44.7  19  82.6 
Pelvic exams (inspection of the vulva and vaginal 
examination) 
 24  63.2  22  95.7 
Whether specific FGM/C management services were 
provided for women/girls who have had FGM/C-related 
complications 
 24  63.2  16  69.6 
FGM/C management services       
Episiotomy  18 47.4  15  65.2 
Counselling  11  28.9  13  56.5 
Control of bleeding  4  10.5  2  8.7 
Management of VVF  0  0.0  1  4.3 
Antenatal care  37  97.4  23  100 
Childbirth/delivery  36  94.7  22  95.7 
Assisted vaginal delivery  5  13.2  13  56.5 
Caesarean section  1  2.6  22  95.7 
Postpartum care  35  92.1  21  91.3 
Post-abortion care  22  57.9  22  95.7 
Essential newborn care  37  97.4  21  55.3 
Child immunisation   38 100  14  60.9 
Child growth monitoring   34  89.5  16  69.6 
Emergency outpatient care  36  94.7  23 100 
Psychological/psychiatric services  8  21.1  9  39.1 
Typology of psychological/psychiatric services (n=16)       
Counselling  5  13.2  4  17.4 
Give drugs and injection  2  5.3  2  8.7 
Management of mild cases  0  0.0  2  8.7 
Manage schizophrenia, depression, drug 
abuse/addiction 
 0 0.0  1  4.3 
Sexual and gender-based violence treatment and 
counselling  
 21  55.3  21  91.3 
Laboratory services  25  65.8  22  95.7 
       
Availability of protocols and guidelines        
Availability of protocols and guidelines in the facility (n=61)  34 89.5  12 52.2 
Use of protocols and guidelines (n=54)  31 81.6  12 52.2 
Whether available protocols and guidelines for delivering 
reproductive health have been reviewed in the last five 
years (n=54) 
 
31 81.6  12 52.2 
Whether latest version of protocol is available (n=51)  31 81.6  11 47.8 
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Supervision of health facilities and availability of protocols and guidelines 
Supervision of health facilities helps to ensure service readiness by monitoring the 
implementation of services and addressing real-time service gaps that might occur. As a result, 
supervision ensures quality of services, especially those focused on FGM/C.  
The average number of weeks between supervisory visits to facilities was 9.0±12.5 weeks, the 
median was 5 weeks with the minimum and maximum number of weeks being 0 and 52 weeks, 
respectively. Less than half (42.6%) of the health facilities assessed were visited 5 weeks or less 
before the assessment, while 36% of health facilities were visited 6 weeks or more before the 
assessment. As shown in Table 4, the Imo State Ministry of Health visited more (41.4%) health 
facilities than other organisations. During visits, supervisors inquired about service problems 
(66.7%), examined records (82.8%), and made suggestions for improvement (69%). Few 
supervisors were reported to check infrastructure (5.2%), check basic equipment (1.7%), check 
essential drugs (3.4%), and check staffing (3.4%).  
Table 4: Supervision of the health facilities from the Health Facility Assessment (HFA) 
Information on supervision per health facilities (n) Percent 
Number of weeks before assessment that facility was visited (n=61   
None 13 21.3 
≤5 26 42.6 
6–10 11 18.0 
≥11 11 18.0 
Mean = 9.0±12.5 weeks; Median = 5 weeks; Minimum = 0 week; Maximum = 52 
weeks 
 
  
   
Organisation that visited health facilities (n=29)   
Imo State Ministry of Health 12 41.4 
Government – Local Government Area 7 24.1 
Hospital Management Board 4 13.8 
State Primary Health Care Development Agency 3 10.3 
Federal Ministry of Health 1 3.4 
Nongovernmental Organisation 1 3.4 
State Ministry of Finance 1 3.4 
   
Whether the supervisor: 
Observed the delivery of service (n=56) 
 
36 
 
64.3 
Inquired about service problems (n=57) 38 66.7 
Examined records (n=58) 48 82.8 
Made suggestions for improvement (n=58) 40 69.0 
Checked infrastructure (n=58) 3 5.2 
Checked basic equipment (n=58) 1 1.7 
Checked essential drugs (n=58) 2 3.4 
Checked staffing (n=58) 2 3.4 
 
Health-based interventions  
Training of health workers and inclusion of FGM/C topics (prevention and management of 
complications) into the health-professional training curriculum was considered a key component 
of health-based interventions. Participants at state and federal levels pointed out that a smaller 
version of these trainings was organised for health workers who work with girls and women at the 
community level. Healthcare workers were also sensitised on how to educate pregnant women 
about FGM/C and examine newborns who were brought to the facilities for weighing and 
immunisation. Health workers were expected to fill FGM/C reporting forms and pass them to the 
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state authorities. Private health facilities and traditional cutters in Imo State were also trained on 
harmful effects of FGM/C as well as referral pathways for clients who have undergone FGM/C 
and experienced complications. These activities were carried out by the Ministry of Gender 
Affairs and supported by UNFPA.  
Complications of FGM/C 
Participants who provide FGM/C services reported that they had provided treatment and care for 
a wide range of complications as shown in Table 5. Some of the immediate complications 
mentioned were bleeding and infections, while long-term complications were clitoral cyst, 
Vesicovaginal Fistula (VVF),  vaginal adhesions, keloids, difficulty with labour/delivery and 
psychosexual dysfunction. 
Management of immediate and long-term complications 
There was consensus among health service providers that the management of FGM/C 
complications was guided by three key factors—the severity of the complication, the availability 
of the right equipment and supplies to manage complications, and the expertise of the health 
service provider. In instances where a patient with severe bleeding as a complication of FGM/C 
presented at a primary healthcare clinic with no access to blood transfusion services, the patient 
was stabilised and immediately referred. A health service provider also reported an instance 
where a patient with VVF was stabilised, treated for urinary tract infection, and then referred to a 
fistula repair centre for further treatment.  
Psycho-sexual complications 
There were mixed views among stakeholders in Imo State on the occurrence, importance, and 
management of psycho-sexual complications. While some did not view it as important enough to 
warrant treatment/counselling, others felt it was an important complication that required more 
attention than it was currently getting. Some of the complications mentioned include sexual 
dysfunction, dyspareunia, and depression. Counselling of the woman and her partner was 
considered critical in the management of psycho-sexual complications. In addition, a health 
service provider highlighted the importance of home visits and sex education. Health service 
providers, however, reported that they did not have technical expertise to conduct psychotherapy 
and provide other psychological services needed. Women who needed surgical procedures for 
vaginal stenosis or required mental health services were referred to specialists. 
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Table 5: Health service providers’ perception of immediate and long-term complications of FGM/C from Focus Group Discussions and Clinical 
Conference with Service Providers 
 
Complications type  Management  
Bleeding  For bleeding, it depends on the severity of the bleeding. If it is a minor one, l will arrest it by applying pressure for a long time and it stops. 
But when the bleeding is much and the child has stayed too much at home, we refer to the hospital for further management. Sometimes they 
do transfusion and at times they suture that region —Nurse/midwife 
 
When I was in Osu, I delivered a child. The mother-in-law of the lady insisted that the child will be circumcised. I usually give a health talk on 
the implications of FGM/C. After I instructed them, they went home. These young mothers are often intimidated. This mother-in-law took the 
baby to a local TBA [traditional birth attendant]. After circumcision, the bleeding became uncontrollable. They had no other option than to call 
me back to arrest the bleeding. When I got there, I was mad at them. But by His mercy, I was able to arrest the bleeding and the child 
survived. —Nurse/midwife 
 
Infections If it’s an infection, you culture the organism then you treat. —Medical doctor 
 
Clitoral cyst A patient comes with clitoral cyst, naturally the patient will ask “but Doctor, what may have caused this?” You know, ladies being what they 
are, the next thing is that [they will ask], “is it infection?” It’s the commonest thing and any doctor will just explain, “well, this is because you 
did female genital mutilation.” And what can be done about it?”’We’ll have to remove it and of course, if you do it for your daughters, it will 
happen.” —Clinical Conference participant 
 
Urinary tract 
infection 
 
During the visit we saw a 6-year-old girl; she [was] having this urinary tract infection as a result of the mutilation. The UNICEF and the World 
Health representatives that accompanied us to the programme took her to Abakaliki where they told the parents that they will keep on 
managing the girl till 12 years where she will be corrected through operation. The girl is now on medication. —Nurse/midwife  
Constriction of the 
vagina and 
vesicovaginal fistula 
 As a gynaecologist, when we see such patients ... with constriction of the vagina, most times we can do what we call vaginoplasty, just a 
reconstructive surgery.… Sometimes we can actually do a reconstructive surgery vaginoplasty for a patient. [But many] of them can also 
come with what we call vesicovaginal fistula especially in the north where they usually do Angura or Gishiri cuts. There’s a fistula repair 
centre we have in the south east, in Ebonyi state; most times we refer them where the treatment is free. So, most of them can come with 
fistula so we do a fistula repair either trans-abdominal or trans-vagina. —Medical doctor 
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Labour and delivery 
complications 
 
 
 
 
 
 
 
That scar tissue formation makes a child unable to come out because of the vagina and the other parts that assist during delivery should be 
elastic but because of the scar tissue formation, it makes it to be stiff. This can lead to bleeding and the woman deliver through caesarean 
section because the head of the child will not pass through the birth canal because of the scar tissue formation. —Clinical conference 
participant 
 
I have also worked in a labour ward, where a young lady came; she was already in labour. When they wanted to examine her, the first 
midwife went and told the senior midwife, “sister, I didn’t see where to put my hand (finger).” I went there; her vagina was completely sealed 
with a small opening.… So, this is a clear case of CS, it was done, and another surgery was done on the vulva, it was separated… —
Nurse/midwfe 
Psycho-sexual complications 
Sexual 
dysfunction/vaginal 
stenosis 
The most we know is to talk to them to relax; fear is already in them so there is a lot of counselling to ensure that that fear is removed. 
Then the next thing is to teach them other methods of sexual acts that will enhance their pleasure, but if there is a problem with penetration 
it means you ... refer, but I am yet to come up with such a case....  —Nurse/midwfe 
You try as much as possible to talk to the woman, if there is nothing much you can do and there are not so [many] drugs that can help in this 
situation, all you need to do is to talk to the woman and then educate her on the better way to enjoy sex because some of them do not even 
know. They think that the reason that makes them enjoy sex is the clitoris but there are other things that you can apply in the foreplay. So 
you now need to train the woman there and then, that “look at what to do and then extend your foreplay, and before you know it you now 
begin to enjoy yourself like others who have not been mutilated” —Medical doctor 
  
Sexual dysfunction 
(psychological) 
 
 
 
 
When it goes beyond what you can handle, where probably the person has started displaying some mental disorder when it begins to affect 
the person’s sanity, that is where you know that you should direct the person to the right place. But if it borders on just emotions and not 
something that is causing depression you can counsel the person based on the knowledge you have—that this thing has been done for 
years and you should not allow it to affect your life like I said; you can bring your partner into it and let the person know that this person can 
still have a normal sexual life. —Nurse/midwfe  
This psychotherapy now is for that kind of woman and the husband. If you get a man who has slept with different women before getting 
married, in most cases, the person may have had different experiences, you get what I’m saying. You have to give psychotherapy to the 
man, to know that it is not the woman’s fault because she did not cause it. So, he will be able the follow such a woman at her own pace so 
she wouldn’t feel bad because if she is neglected by the husband, because of that, she will also suffer some psychological trauma, which the 
damage has been done and nothing can be done about it. You should explain to both of them and they can live together based on the love 
they share and understanding between her and the partner. —Nurse/midwife  
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Preparedness to manage and prevent complications 
Health service providers were asked about their perceptions of facilities and providers’ readiness 
to respond effectively to the prevention and management of FGM/C complications. A majority of 
nurses and community health extension workers (CHEWs) expressed a willingness to address 
issues relating to FGM/C and were involved in raising awareness in the communities, holding 
talks in the clinics, and discouraging traditional cutters from continuing the practice. 
Unfortunately, they were limited by a variety of factors like lack of training and availability of 
supplies. Therefore, readiness to manage complications was broken down into components such 
as adequate knowledge/expertise, availability of equipment, and a good referral structure. 
Referral 
Minor cases such as mild bleeding, STIs, and urinary tract infections were managed in primary 
health centres or private health facilities and referrals were made to either secondary or tertiary 
facilities for severe (severe bleeding, keloids) cases. There was a consensus among health 
service providers that it was better to refer as quickly as possible to ensure that the patient’s 
condition does not deteriorate.  
“In our facilities… I’m talking about private sector, when that kind of complication comes 
to you, and you assess this child. There is nothing you can do apart from first aid and you 
refer the child. You cannot do what you don’t know how to do. So instead of treating or 
curing the baby, you end up sending the baby to the grave. The best thing is to do the 
one you can and refer to a secondary or tertiary facility....”  
—Nurse/midwfe from focus group discussion  
“We have not done any referral because this is a secondary level of the health facility. 
The doctors are here, the nurses are here. We are trained nurses and midwives, who can 
even suture any first-degree, second-degree, or third-degree tear when it arises without 
the doctor being around. Because if you wait for the doctor to come, the woman might 
bleed to death.…What we don’t do is go into the theatre to do caesarean section....”  
—Nurse/midwfe, In-depth state interview  
Assessment of referral system at health facilities 
 
Referrals are important in determining the scale and quality of services received. In most 
practising communities, the primary and secondary facilities are the first port of call in addressing 
health issues, especially FGM-related. However, since a major proportion of the FGM/C 
complications require specialist care, it is crucial to assess how such cases have been referred 
across healthcare levels.  
 
A referral system was in place in 86.9% of the health facilities with the proportion of PHCs and 
secondary/tertiary being 81.6% and 95.7%, respectively. The majority of PHCs (81.6%) and 
secondary/tertiary facilities (82.6%) had ever referred a case. The majority (68.4%) of PHCs had 
made ≤20 referrals while 13.2% had referred ≥21 referrals per year. Less than half (47.8%) of 
secondary/tertiary facilities made ≤20 referrals while 34.8% had made ≥21 referrals per year. 
This information is presented in Table 6 below.
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Table 6: Referrals for clients from Health Facility Assessment (HFA) 
Referral system at the facility level  PHCs (n=38)  Secondary/tertiary (n=23) 
  (n) Percent  (n) Percent 
Existence of a referral system   31  81.6  22 95.7 
Ever referred   31 81.6  19  82.6 
Frequency of referrals per year        
21 or more referrals   5 13.2  8 34.8 
20 or fewer referrals   26 68.4  11 47.8 
Services clients are referred for       
FGM/C complications   2  5.3  2  8.7 
STI  7  18.4  4  17.4 
HIV/AIDS   17  44.7  8  34.8 
Family planning   4  10.5  4  17.4 
Antenatal care   6  15.8  3  13.0 
Postpartum care   2  5.3  3  13.0 
Essential newborn care   2  5.3  5  21.7 
Child immunisation   1  2.6  5  21.7 
Complicated labour   2  5.3  6  34.8 
Blood transfusion   5  13.2  5  21.7 
Surgery   1  2.6  2  8.7 
Bleeding/haemorrhage   3  7.9  0 0.0 
Delivery   2 5.3  1  4.3 
Feedback after referral   18  54.5  15  65.2 
 
Knowledge/expertise to handle complications 
Participants opined that health service providers in tertiary facilities were better equipped to 
handle complications compared to those in primary health facilities because of better exposure of 
the former to capacity-building opportunities. There were, however, gaps in expertise at the 
tertiary centres in handling severe complications such as extensive scarring, fibrosis, and 
gynaetresia (narrowing of the female genital tract). There was a consensus that the government 
was not doing enough to improve and strengthen health service providers’ skills in the state. 
Unfortunately, PHC facilities, which were closest to the girls and women who needed the 
services most, were poorly equipped to handle prevention activities.  
“The higher level may be equipped with that knowledge but at the lower level I believe 
that the majority of them are not really equipped with the knowledge. But for you to really 
go and teach somebody so that the person will abstain from it you must, first of all, know 
the complications. Some people just hear FGM, “don’t circumcise”, they don’t know. They 
are still health workers, they don’t know the complications involved in it, so that’s why 
when participant seven talked earlier today about training and retraining of the health 
workers it’s a very vital area. So, I won’t say that all the health workers are equipped with 
the wherewithal to handle complications.”  
—Medical doctor from focus group discussion 
Perception of quality of care 
Across the interviews, health service providers and clients reported that the quality of care for 
FGM/C clients was low. Nurses complained that non-inclusion of FGM/C topics in the nursing 
training curriculum limited their capacity to handle complications. Lack of knowledge about 
FGM/C management, poor working conditions in Imo State, the lack of materials/equipment, and 
inadequate staff were cited as key issues affecting the quality of care. For tertiary institutions, 
lack of funding and an inadequate number of skilled personnel were two key drivers of quality 
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care for FGM/C. Some providers noted that the quality of care was higher in tertiary health 
institutions than in lower-level facilities. 
For tertiary health institutions, I believe they receive quality standard care because we 
have an in-built mechanism that within the arrival of the patient to the unit obstetric 
emergency or paediatric emergency, 30 minutes is the standard time set to do all things 
humanly possible, collect the blood sample, cross-match the blood, if it is for bleeding, 
within 30 minutes, that's half an hour we have already done all these and there should be 
blood ready for obstetric and gynaecology services…everything you needed either to 
suture this woman with or without deposit will be ready and the quality of care given is a 
quality nursing care that is standard. 
—Nurse/midwfe from focus group discussion 
From a client perspective, poor resolution of symptoms after treatment was considered a defining 
issue for quality of care. Complete resolution of symptoms was considered an indication that the 
quality of care received was good. 
 
“I wanted it to heal. I didn’t want such, it’s embarrassing. Why I kept quiet is because my 
husband is not with us. Had it been he was with us ...(hisses) it is somehow now. So 
that’s why I just kept it for mysel.f… I was not satisfied, I was not. Like I told you, I cannot 
say that the repair has been totally done. It failed.”  
—In-depth client interview  
Logistics, infrastructures, and supplies  
Some of the barriers to FGM/C management identified by health service providers included: poor 
funding, lack of access roads to rural communities, lack of communication materials, and lack of 
political will. Prevention activities were hindered by poor funding for activities, which meant that 
health service providers could not deliver health talks and organise engagement meetings in 
rural and hard-to-reach communities. Some of the rural areas also lacked access roads. Health 
workers also lacked communication materials such as pictorial images depicting the types of 
FGM/C and complications to facilitate easier conversations with community members. Poor 
functioning of the PHC system meant overburdening the tertiary facilities.  
“Like in our facility, our environment is very far from the facility. But if we say let’s go to 
home visit, like today, you will see that there are some communities you cannot go until 
two days after this rain, due to bad roads so if you don’t have enough money or mobile 
something, you cannot go.”  
—-Community health worker focus group discussion  
“The current health system in Nigeria is not surprising. [It is] epileptic. The health sector 
is saddled with so many things and there is a lot of poverty in the land. When it comes to 
the girl child or the child health, there are a lot of programmes [that are] well-funded and 
that is where you see public health workers going into. For female genital mutilation I will 
say there is nothing on the ground now, even for information collection to say nothing of 
planning, to say nothing of implementation. I will say the health system now is poor or not 
ready.”  
—Medical doctor, state focus group discussion  
Monitoring and maintenance of equipment and information on facility infrastructure 
 
Table 7 shows information on facility infrastructure and monitoring and maintenance of 
equipment. Only 56.5% of secondary/tertiary health facilities and 28.9% of PHCs had a system 
for monitoring and maintaining materials, equipment, and supplies. Seventy-eight percent of 
secondary or tertiary facilities used water piped from a borehole compared to 21% of PHCs. Just 
over half (52.6%) of PHCs had electricity as opposed to 95.7% for secondary/tertiary health 
facilities.  
 29 
 
Table 7. Monitoring and maintenance of equipment and information on facility 
infrastructure from the Health Facility Assessment (HFA) 
% of facilities with a system for monitoring and 
maintenance of equipment and information and 
facility infrastructure  
 PHCs (n=38) Secondary/tertiary (n=23) 
 (n) Percent  (n) Percent 
System for monitoring and maintaining materials, 
equipment, and supplies  
 11  28.9  13  56.5 
Availability of waiting area with shelter from sun and rain at 
the facility  
 37  97.4  23  100 
Where pelvic exams and STI testing take place        
Separate room, with no ability to see into the room from 
outside 
 37  97.4  22  95.7 
Behind a curtain  1  2.6  1  4.3 
       
Source of water        
Water piped from borehole  8  21.1  18  78.3 
Purchase water from borehole  9  23.7  1  4.3 
Public tap  6  15.8  2  8.7 
Public borehole  7  18.4  0  0.0 
Rainfall  5 13.2  1  4.3 
No running water available  4  10.5  0  0.0 
Public well  1 2.6  1  4.3 
Stream  1  2.6  0 0 
Availability of electricity   20  52.6  22  95.7 
Source of electricity        
Generator and power from the electricity distribution 
company 
 5  13.2  9  39.1 
Generator alone  2  5.3  8  34.8 
Power for electricity distribution company alone  9  23.7  0  0.0 
Power from the electricity distribution company, generator, 
and solar 
 0 0.0  3  13.0 
Solar and power from the electricity distribution company  2  5.3  0 0.0 
Power from the electricity distribution company, generator, 
and inverter 
 0  0  1  4.3 
 
Health workforce 
The shortage of manpower for FGM/C programmatic activities and health care was considered a 
major hindrance to FGM/C activities in the state. New personnel were not being employed by the 
state despite the continued retirement of existing personnel. Personnel who were available 
provided suboptimal services because they lacked supplies, had limited capacity/training, had a 
heavy workload, and lacked transportation to reach communities under their jurisdiction. One key 
informant noted that although 27 new general hospitals had been commissioned, poor manpower 
meant that the facilities were underutilised. A midwife corroborated this by saying that even 
where infrastructure was available, there were no materials or nurses to do the work. In the same 
vein, some participants reported that they partnered with NGOs and development partners like 
UNICEF, to receive FGM/C-specific training.  
 “Shortage of manpower. Nurses should be engaged in secondary and primary 
healthcare levels. We have a serious shortage of nurses in particular. If you go to some 
general hospital you will see just two nurses covering morning shift and evening shift in a 
whole general hospital. Because of this you will see that they might not work well 
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because they are human beings not machines. There is a need to employ staff at the 
secondary and the primary healthcare level, I don’t know about the tertiary level, maybe 
they have.” 
—Community health worker from focus group discussion  
“I always feel that our greatest problem is human resource as it affects healthcare 
professionals. When you have hospitals with 250 bed spaces and you cannot use up to 
50, how will you be complaining about infrastructure or equipment. You don’t do that and 
currently the governor decided to build 27 brand new general hospitals.…But presently 
what we think is that manpower, improvement in the manpower is the main thing as it is 
now…What we are doing right now is that, in most of our hospitals now, when the 
shortage of staff is very acute, mainly nurses, we hire local nurses, possibly the retired 
ones and pay them some stipends so that they continue to help our system to function…”  
—Key informant, state policymaker interview  
Staffing per facility type  
With respect to secondary/tertiary facilities, 82.6% employed two or more medical doctors, only 
30.4% employed obstetricians and gynaecologists, with 17.4% employing just one. About 1 in 4 
(26.1%) secondary/tertiary health facilities employed two certified nurses or more. Certified 
nurse/midwives were employed at 95.7% of secondary/tertiary facilities with 78.3% employing 
two or more. In contrast, less than half (47.4%) employed nurse/midwives at PHCs with 31.6% 
employing just one. Community health extension workers (CHEWs) were the major type of 
community health workers employed by health facilities with the majority (61.2%) employed at  
thePHC level. Less than half (47.4%) of PHCs employed two or more CHEWs. A detailed 
breakdown is presented in Table 8 below.  
Table 8: Staff employed per facility type from the Health Facility Assessment (HFA) 
Type and number of staff employed 
per facility  
 PHCs (n=38)  Secondary/tertiary (n=23) 
  (n) Percent  (n) Percent 
Medical doctor         
1  7  18.4  3  13.0 
≥2  0  0.0  19  82.6 
Obstetricians and gynaecologists        
1  0 0.0  4  17.4 
2  0  0.0  3  13.0 
Certified nurse        
1  1  2.6  3  13.0 
2  0  0.0  6  26.1 
Certified nurse/midwfe        
1  12  31.6  4  17.4 
≥2  6  15.8  18  78.3 
Community health officer        
1  5  13.1  0  0.0 
2  0  0.0  1  4.3 
Junior community health extension 
officer 
      
1  7  18.4  0  0.0 
≥2  6  15.8  2  8.7 
Community health extension officer       
1  14  13.8  0 0.0 
≥2  18  47.4  3  13.0 
Psychologists        
1  1  2.6  2  8.7 
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Type and number of staff employed 
per facility  
 PHCs (n=38)  Secondary/tertiary (n=23) 
  (n) Percent  (n) Percent 
Social worker        
3  0  0.0  1  4.3 
Laboratory scientists        
1  3  7.9  12  52.2 
2  0  0.0  4  17.4 
Laboratory technicians        
1  5 13.1  6  26.1 
2  2  5.3  5  21.7 
Health educator       
1  3  7.9  3  13.0 
2  2  5.3  1  4.3 
Counsellor        
1  0 0.0  3  13.0 
≥2  0  0.0  1  4.3 
Health assistants       
1  18  47.4  0 0.0 
≥2  9  23.7  0  0.0 
Pharmacists        
1  0  0.0  2  8.7 
 
According to the minimum standards for primary health care in Nigeria, it is recommended that if 
available, there should one medical officer—usually a medical doctor—attached to PHCs. A PHC 
should have at least four nurse/midwives, one community health officer, three community health 
extension officers, and six junior community health extension officers. Table 9 shows the 
recommended health personnel and number per primary healthcare facility. 
Table 9: Recommended personnel for primary healthcare centre 
Recommended personnel of the facility  Recommended 
personnel per facility 
Medical officer (a medical doctor if available)  1 
Nurse/midwife  4 
Community health officer  1 
Community health extension officer  3 
Junior community health extension officer  6 
Environmental officer  1 
Medical records officer  1 
Pharmacy technician  1 
Laboratory technician  1 
Health attendant/assistant  2 
Security personnel  2 
General maintenance staff  1 
 
Health information system 
Having a concrete information system on FGM/C at the health facility level is important to 
understand the real-time pattern and burden of the practice. Just like data are collected on other 
health issues, availability of data on FGM/C shows that health system is ready to address the 
practice as data gathered allow for ease of FGM/C-focused programming.  
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Collection of FGM/C data 
FGM/C data is not part of the variables assessed for the National Health Information 
Management System and most (91.8%) of the health facilities did not record the FGM/C status of 
women and girls (Table 10). Data on FGM/C status were recorded on case notes, checklists and 
delivery charts. Because FGM/C-related data were not collected at the health facilities, service 
providers noted that it was difficult to track new cases and most patients who presented for care 
were lost to follow-up/tracking and feedback. Similarly, cases of FGM/C complications were not 
recorded by 85.7% of the health facilities.  
 
Table 10: Collection of FGM/C data 
Information on FGM/C data collection (n) Percent 
Whether health service providers record FGM/C status (n=60) 5 8.2 
   
Where FGM/C status is recorded (n=5)   
Case notes 2 40 
Checklists 2 40 
Delivery chart 1 20 
   
Whether cases of FGM/C complications are recorded (n=60) 5 8.2 
   
Where cases of FGM/C complications are recorded (n=5)   
Case notes 3 60 
Delivery chart 1 20 
Patients’ card 1 20 
Reasons given by health service providers for not documenting FGM/C cases included 
perceptions that the practice of FGM/C had reduced/stopped, there was inadequate manpower 
to capture records, and that there was no provision to capture FGM/C status in the facility 
register.  
We have registers, registers bear their columns, but there is no register that bears the 
columns of where we can put the record. But all I know is that when a patient comes in 
with any condition, in our admission register, we have a column that bears diagnosis, so 
if a patient comes with such a case the diagnosis will be that.  
—Medical doctor, in-depth interview 
We don’t even keep track of them, where we keep track of them is when they come to 
you for family planning, insertion of IUCD, and then during their birth that is when you will 
know it, and we use that opportunity.… “Please since you are circumcised you don’t have 
to circumcise your female babies, I know you have not been finding things easy, even 
childbirth. So, you don’t go for it.”  
—Nurse/midwfe, in-depth interview  
Underpinning the lack of documentation for FGM/C was the poor knowledge among health 
workers on the importance of documenting FGM/C-related cases. For example, a health worker 
reported that she did not see the need to record the details of patients who already had FGM/C 
,as the practice cannot be undone. Another nurse from a general hospital reported that the 
hospital where she worked does not keep track of women and girls who were cut, but did so 
when they encountered a woman who was cut who presented for family planning or delivery 
services. The service providers took a mental note of those who were cut, in order to sensitise 
them and to discourage the practice, as the concern was to prevent younger girls from being cut 
as well. One nurse, however, noted that she keeps FGM/C records in her facility. Health service 
providers noted their willingness to receive guidance on how to keep FGM/C records and 
improve documentation in the future.  
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FGM/C routine data collection challenges  
The national representative of the DPRS reported that the routine data challenges were related 
to the fact that secondary facilities did not report on the same platform as the primary healthcare 
centres and private health facilities do not report data at all. The UNJP was planning to introduce 
FGM/C data columns in the register and, ultimately, on the District Health Information Software 
(DHIS) platform. However, there were concerns that the UNJP only works in five states, which 
would limit the coverage for representative data gathering. In addition, a policymaker noted that 
data collection would be suboptimal if health workers were not trained on how to counsel a 
patient who had undergone FGM/C or document FGM/C status or complications. The level of 
preparedness at facilities for FGM/C services was also noted to impact the capacity of health 
workers to report FGM/C indicators. There was a consensus that training was needed to ensure 
the health system was prepared to report data on FGM/C.  
…my issue with FGM, it's one thing for you to put data on the platform, it is another for 
you to plan accordingly. Is the health system offering this service?...For example now, we 
put counselling because UNFPA pushed for counselling, fine they are working in five 
states. What is the level of awareness of people working in other states, even in [those] 
five states? Because you can’t give what you don’t have. Now we are putting FGM on 
counsel, have they been trained on how to counsel people? At the end of the day in the 
next two, three years…that data will be there, but it will be redundant so of what use than 
to just remove it and put another thing…? 
—Key informant, national policymaker interview 
Availability of medicines, equipment, and supplies 
As discussed earlier, poor funding affected the preparedness of health facilities to implement 
FGM/C-related activities. The lack of funding affected the availability of information, education, 
and communication (IEC) materials, pictorial guides, and videos to educate people on FGM/C. 
Some participants, however, mentioned that they sometimes received FGM/C-specific IEC 
materials and job aids from international NGOs, and development partners for use in FGM/C 
activities; at other times, they improvised. 
Limited funding also impacted on outreach workers’ ability to conduct activities and home visits in 
the rural areas because of lack of accommodation, public address systems, vehicles. The poor 
state of roads and insecurity also limited outreach workers’ activities.  
“…Other stakeholders hindering us from winning the war against FGM include good 
roads, communication, how do you get to this women—even when you pump in money 
into a system and there are no good roads—to these areas, especially those in the 
creeks, in the hinterlands where these things are prevalent… there is also a place of the 
mass media…” 
—Medical doctor from focus group discussion 
“In terms of the readiness of the health system to tackle FGM in Imo State I will say that 
we are not ready. I remember in one of the occasions that I was given one pamphlet on 
FGM and why it must be stopped; if we have such pamphlets scattered all over the place, 
distributed to the women, and then we also have materials to show them some pictorial 
views or even some videos on the adverse effects of this… if we are ready we will make 
an avenue to have some of these things—you know leaflets, pamphlets—you have some 
of these preparations that can be shown to some of these women that come to antenatal 
…. you have over 500 women on antenatal, so imagine talking to 500 women and then 
dissuading them from doing this, you have done a great deal, and they will also tell 
others....” 
—Medical doctor from focus group discussion 
  
 34 
 
Availability of equipment and service commodities at health facilities  
A key component of the health system is the availability of equipment and service commodities. 
This is particularly important for FGM/C as related complications emanating from the practice are 
best addressed with these materials. Level of availability of equipment and service commodities 
will show the level of readiness at the facility level. It is worth noting that in this study, the 
equipment and service commodities assessed were those obtainable to address general sexual 
and reproductive health issues and not specific for FGM/C. This is because the FGM/C-related 
complications are similar and mostly fall under the broad sexual and reproductive health 
response.  
 
Few PHCs had the following equipment and service commodities: delivery forceps (28.9%), 
autoclave (15.8%), urine catheter (34.2%), urine bags (2.6%), cervical/vaginal swabs (7.9%), 
strong analgesics (5.3%), intravenous local anaesthetic (36.8%), anti-depressants (5.3%), and 
anti-psychotics (5.3%). For secondary/tertiary facilities, fewer than half had the following: blood 
bank (13%), ultrasound machine (47.8%), strong analgesics (43.5%), anti-depressants (47.8%), 
and anti-psychotics (39.1%). Only two tertiary facilities and a private facility had blood banks. 
None of the general hospitals had a blood bank. A detailed description of the availability of 
equipment and service commodities is provided in Table 11. 
Table 11: Availability of equipment and service commodities based on the Health Facility 
Assessment (HFA) 
% of equipment per health facility  PHCs (n=38)  Secondary/tertiary (n=23) 
  (n) Percent  (n) Percent 
Flashlight/lamp   24  63.2  21  91.3 
Blood pressure measuring equipment   34  89.5  23  100 
Stethoscopes   37  97.4  23  100 
Sterile needles and syringes   37  97.4  23  100 
Vaginal speculum   25  65.8  21  91.3 
Delivery forceps   11  28.9  14  60.9 
Surgical forceps   34 89.5  23  100 
Episiotomy scissors   34  89.5  21  91.3 
Sutures  26  68.4  22  95.7 
Needle holder   23 60.5  22  95.7 
Autoclave   6  15.8  15  65.2 
Sterile swabs or sterile gauze   19  50.0  19  82.6 
Cotton wool  35 92.1  21  91.3 
Sterile gloves   17  44.7  22  95.7 
Disposal containers  38  100  21  91.3 
Examination couch or table   29  76.3  21  91.3 
Functioning delivery bed   25  65.8  21  91.3 
Operating theatre   2  5.3  22  95.7 
Blood bank   0  0.0  3  13.0 
Intravenous (IV) line   29  76.3  18  78.3 
Blood-giving set   0  0.0  14  60.9 
Urine catheter   13  34.2  22  95.7 
Urine bags   1  2.6  22  95.7 
Cervical/vaginal swab   3  7.9  14  60.9 
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% of equipment per health facility  PHCs (n=38)  Secondary/tertiary (n=23) 
  (n) Percent  (n) Percent 
Ultrasound machine   0.0 0.0  11  47.8 
Medicines       
Strong analgesics   2  5.3  10  43.5 
Intravenous local anaesthetic   14  36.8  21  91.3 
Tetanus vaccine   20  52.6  12  52.2 
Folic acid   29  76.3  23  100 
Iron  28  73.7  21  91.3 
Antibiotics   32  84.2  21  91.3 
Non-steroidal anti-inflammatory drugs   29  76.3  21  91.3 
Oxytocin  32  84.2  21  91.3 
Anti-depressants   2  5.3  11  47.8 
Anti-psychotics  2  5.3  9  39.1 
Table 12 highlights participants’ health system–related recommendations on FGM/C. These 
perceived recommendations are ordered according to the six health system blocks.  
Table 12: Participants’ recommendations on FGM/C-related issues 
Recommendations 
Leadership and governance 
(health system and FGM/C 
response stakeholders) 
FGM/C programme integration into existing health facility programmes. 
 Provision of guidelines for the management of FGM/C complications. 
 Engaging youths and educational institutions in the campaign against FGM/C. 
 Improved stakeholders’ collaboration and coordination as well as increased role 
of the Federal Ministry of Health in the FGM/C programmes. 
 United Nations Joint Programme scale-up. 
 Creating awareness through media and educational advocacies 
 Creating awareness about FGM/C practise and associated complications using 
community platforms. 
 Enforcement of anti-FGM/C laws. 
 Provision of alternative income for FGM/C cutters. 
 National Health Insurance Scheme coverage for women and girls who have 
suffered complications. 
 Provision of stipends for state government stakeholders. 
 Provision of specialised facilities for the management of FGM/C. 
  
Funding FGM/C inclusion in the budget for federal and state ministries of health as well as 
women affairs and also increased funding at the facilities.  
  
Strengthening service 
readiness 
Increasing collaboration between health service providers and FGM/C response 
stakeholders to ensure a robust referral of FGM/C complication cases. 
 Providing free services to women and girls who have suffered complications. 
 Sensitisations and awareness using community platforms like August meetings* 
and religious gatherings. 
  
Health workforce Recruit health workforce. 
 Build the capacity of health service providers to prevent and manage FGM/C 
complications. 
  
Health information system FGM/C data documentation at the health facilities. 
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Recommendations 
 
  
Availability of medicines, 
equipment, and supplies 
Provision of job aids, commodities, and supplies for the management of FGM/C 
complications. 
 Provision of infrastructure at the facilities. 
*Communal meeting for women mostly in eastern Nigeria, held yearly in August. 
Discussion  
This study explored the health sector’s role in the prevention and management of FGM/C 
complications as well as the response to FGM/C policies. Similar to the way the findings from this 
study were reported, this section was organised according to the components of the health 
systems framework. As a result, subsections are on the following; leadership and governance; 
financing; service delivery/readiness; health workforce; health information system; and 
availability of medicines, equipment, and supplies. Findings show that the health sector was 
poorly equipped to handle FGM/C prevention and complications because of a lack of capacity, 
and funding and poor political commitment. 
Leadership and governance 
The Nigerian health system has been described as weak because of a lack of coordination and 
fragmentation of services; the inadequacy of resources, drugs, and supplies; poor infrastructure; 
inequity in resource distribution; and poor access to quality care (Nigerian National Health 
Conference 2009). The National Strategic Health Development Plan Framework (2009–15) 
highlighted the need to strengthen the health system to cater to an increasing population served 
by scarce skilled health professionals. Apart from poor budgetary provisions for health, poor 
political will to implement policies has also been identified as a major setback to the health 
system response (FMOH 2010; Omoleke and Taleat 2017). While the effort of the federal 
government at setting up the FGM/C Technical Advisory Committee and FGM/C Technical 
Committee at the three tiers of government is commendable, not much is known about their 
functionality at state and local-government levels.  
Leadership and governance in health systems encompasses the development and 
implementation of appropriate policy frameworks, effective oversight, collaboration, regulation, 
and accountability (UNAIDS et al. 2010). Key indicators include the existence of national policies 
and evidence of their implementation, as well as other determinants of healthcare governance 
including ownership arrangements and stakeholder participation (UNAIDS et al. 2010). Despite 
the existence of laws, policies, and plans of action that should drive the health system’s response 
in Nigeria, study findings reveal several challenges that hinder the effective implementation of 
these policies. 
First, although the involvement of stakeholders at all levels in the development and dissemination 
of law, policies, and action plans is critical to facilitating ownership and implementation at the 
community level, participation of stakeholders in policy and action planning at the state level 
appears to be limited. This nonparticipation may stifle the implementation of laws, policies and 
plans of action. For example, the repeal of the VAPP Act, which is the only national law that bans 
and criminalises FGM/C, at the state level was attributed to the limited engagement of 
stakeholders as part of the policy formulation process. Poor engagement and inclusion of private 
sector stakeholders were also reported as a major challenge to implementation of FGM/C 
policies.  
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Second, poor coordination of inter-ministerial roles; weak linkages between complementary 
ministries, departments, and agencies; and duplication of roles between them may impede the 
FGM/C response both at state and national levels. Unfortunately, the 1999 Constitution of 
Nigeria and the 2014 National Health Act, which serve as legislative frameworks for governance, 
are not clear on shared responsibilities of the three tiers of government for health systems 
(FMOH 2016). This could have huge implications in terms of provision of resources by 
government for health services. If responsibilities are not well mapped out, especially where they 
converge and diverge, there is the possibility of duplication of efforts or, worse, abdication of 
responsibilities. 
Third, stakeholders reported that FGM/C is a low priority on government’s agenda, hence has not 
been considered an issue of public health importance. Government ownership and prioritisation 
of FGM/C-related programmes ultimately affects sustainability. This further implies that the 
FGM/C response will not be effective enough for a sustained change. Additionally, the 
abandonment efforts will be limited to a reduced proportion of the country.  
Financing 
The health systems framework suggests that a good health financing system is able to raise 
adequate funds for health (WHO 2010). In the same vein, it has been stated that at the extreme, 
without the necessary funds, no health workers would be employed, no medicines would be 
available, and no health promotion or prevention would take place (WHO 2010). Also, financing 
is expected to be achieved in ways that ensure clients can use needed services without being 
impoverished or plunged into financial catastrophe associated with having to pay for them (WHO, 
2007). From this study, there was a consensus that gaps in funding constitute the most 
significant barrier to FGM-related prevention and management activities in terms of policy 
dissemination, implementation, and domestication at both federal and state levels. This gap, 
which was identified at two levels—poor budgetary provision and poor disbursement—stifled the 
capacity of the coordinating ministries (Women Affairs and Health) to implement programmes to 
prevent and manage FGM/C. This pattern is consistent with evidence from a public expenditure 
review of the health sector, which suggests that, on average, most states in Nigeria spend less 
than 5% of their total outlay on health care. Expenditure from all tiers of government amounts to 
less than 6% of total government expenditure in the country (Ichoku and Okoli 2015). The 2016 
National Health Policy also reports that total allocation from the federal budget to health rose 
from 3.9% to 6% between 2010 and 2012 but fell again to 4% in 2013. The policy further 
reinforced that there was a paucity of data on the state budgetary allocation to health (FMOH, 
2016). A recent health budget analysis for Nigeria (BudgIT 2018) revealed that the health budget 
of Imo State was not publicly available, which makes it difficult to ascertain the level of spending 
and financial accountability of health systems in the state. 
 The paucity of funds to drive activities in Imo State has led to poor planning, supervision, and 
coordination of FGM/C activities in the state. Poor political will and lack of commitment from both 
federal and state governments for FGM/C programmes explain the over-reliance on the UNJP for 
financing activities and threatens sustainability after the donor exits. For example, the funding for 
donor agencies was reported to have dwindled, resulting in non-operationalising of some 
activities on the action plan for the Federal Ministry of Health. The reliance on donor funding for 
projects also skews implementation in favour of donor-priority states and donor-focused activities 
as seen in this study. This negatively impacts the capacity of the government to achieve scale in 
addressing emerging issues relating to FGM/C in other states. Within the context of limited 
resources, stakeholders’ recommendation that prevention activities should be prioritised as a 
means of cost-effective FGM/C response is commendable. Similarly, to improve cost-
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effectiveness, integrating FGM/C with other programmes to prevent overlap and duplicates is 
essential, but care must be taken such that such programmes do not overshadow FGM/C.  
Service delivery/readiness 
According to the WHO health systems framework, a good health system is one that delivers 
effective, safe, quality personal and nonpersonal health interventions to those that need them, 
when and where needed, with minimum waste of resources (WHO 2007). This was evident in 
efforts made to address the practice at the state level. For example, in Imo State, the use of 
sensitisation, outreach, and visitations led to increased awareness of the practice because they 
targeted women’s groups, August meetings, and utilised local influencers such as FGM/C 
champions and traditional leaders to advocate for its abandonment. The integration of FGM/C 
topics into antenatal care at PHCs is commendable as majority of the health facilities assessed 
provided such services. These efforts must be reinforced by sustained engagement of traditional 
cutters to develop alternative means of livelihood and ultimate abandonment of the practice. The 
gaps in training and data management highlighted by health service providers need to be 
urgently addressed to forestall complete failure of the health system’s response. The inclusion of 
FGM/C in the curriculum of health training institutions was limited to the training of CHEWs, but 
not nurses, midwives, and doctors, reflecting a huge capacity gap. The absence of guidelines for 
the management of complications of FGM/C implied that health workers utilised their best 
judgement to evaluate the needs of their patients and in some instances make urgent decisions 
about treatment and referral. The challenge with this approach is that there may be 
inconsistencies in treatment approach and outcomes that could significantly impact the quality of 
care. This is more so because health workers consistently complained about the lack of training 
opportunities, meaning that they may not have the technical competence required to manage 
FGM/C complications without guidance.  
The findings from the qualitative interviews regarding the treatment of complications are 
reinforced by the findings from the HFA showing that the provision of FGM/C-specific services 
was limited. As health workers indicated, the capacity to provide support for psycho-sexual 
complications of FGM/C was limited and only a few facilities provided psychological/psychiatric 
services. The overall level of preparedness of the health facilities to handle FGM/C related 
complications was relatively low as evidenced by poor infrastructure and lack of equipment and 
human capacity. The low referral rate for FGM/C may be a combination of factors such as late 
presentation, lack of technical competence to properly diagnose FGM/C complications, and lack 
of infrastructure/logistics to support the referral process. The lack of guidelines and protocols for 
management of FGM/C at all levels in the state reflects the poor readiness to manage FGM/C.  
Health workforce 
For a health workforce to be regarded as a high-performing one, it is expected to be responsive, 
fair, and efficient, to achieve the best health outcomes possible, given available resources and 
circumstances (i.e., there are sufficient staff, fairly distributed; they are competent, responsive 
and productive) (WHO 2010). Also, it has been stated that the ability of a country to meet its 
health goals depends largely on the knowledge, skills, motivation, and deployment of the people 
responsible for organising and delivering health services. (WHO 2010). A huge gap found in this 
study was the lack of knowledge for FGM/C-specific prevention and management. While FGM/C 
has no specific services to distinguish it from other reproductive health issues, it is important that 
health service providers have a clear understanding of what to do when they come in contact 
with FGM/C-related complications or find themselves in position to advocate for the 
abandonment of FGM/C. A study on innovative training approaches for nurse/midwives in high-
prevalence settings found that there was need for training interventions to increase the 
knowledge and empower health workers for management of FGM/C-related complications and 
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prevention (Kimani et al. 2018). Another study highlighted the importance of training and 
increasing the awareness level of healthcare providers (Kimani, Muteshi, and Njue 2016).  
The HFA highlighted the issues with shortage of manpower at all levels of care. For example, the 
low number of obstetricians and gynaecologists in secondary and tertiary facilities reflects 
potential gaps in readiness for management of long-term complications of FGM/C. Similar 
findings were reported by a study in Southwestern Nigeria (Adekanle, Isawumi, and Adeyemi 
2011). The inadequate availability of nurse/midwives at the PHC level is not in line with the 
stipulations of the Minimum Standards for Primary Health Care in Nigeria (NPHCDA 2015).  
CHEWs were the frontline staff across the facilities, reflecting the dearth of health workers in the 
Nigerian health sector. An important indicator of a strong health system is the availability of 
efficient and skilled health personnel (Rigoli and Dussault 2003). However, in Nigeria, it has been 
estimated that the health workforce to population ratio is 1.95 per 1000, and this problem is 
compounded by inequity in health workforce distribution (WHO 2016; Abimbola et al. 2016; 
Gyuse, Ayuk, and Okeke 2018). The weak health workforce majorly stems from inadequate 
resources to employ skilled personnel, brain-drain in the health sector and poor working 
environment. This subsequently results in a weakened health system (Chen and Boufford 2005; 
Ike 2007). This has a series of implications; health workers are stretched because of the 
workload (Willis-Shattuck et al. 2008) and could be forced to render services they are not 
qualified for. To lend credence to this, nurse/midwives who were supposed to be the facility 
heads were not available in many of the facilities assessed (NPHCDA 2015).  
Health information system 
Reliable information is needed for good decisionmaking across all the health system building 
blocks. In view of this, a well-functioning health information system is one that ensures the 
production, analysis, dissemination, and use of reliable and timely information on health 
determinants, health system performance, and health status (WHO 2010). In contrast to this, 
findings showed that issues of FGM/C were not documented at the health facility and, as a result, 
data were almost nonexistent. FGM/C-related data generated from health facilities and the 
community would be helpful in providing information on the incidence of the practice and 
complications. However, insufficient manpower to document FGM/C cases could be a major 
factor contributing to the unavailability of data. One way to efficiently advocate for allocation of 
resources and push for policy implementation regarding FGM/C is the use of timely data. The 
perception that FGM/C was a low priority issue in this study may be related to lack of data. The 
poor orientation of health workers about data management for FGM/C was a key issue identified 
that can be addressed by training. It is possible that cases of FGM/C-related complications that 
occur are not reported at the facilities. This has already been identified by other studies (Mbanya 
et al. 2018). Unavailability of data is a symptom of poor health performance and is synonymous 
with poor policy and decision-making process (Sambo, Lewis, and Sabitu 2005). A review of the 
previous National Health Strategic Development Plan 2010-2015 showed that incomplete or 
missing data make it difficult to know if health interventions are working (Oyibocha et al. 2014).  
Availability of medicines, equipment, and supplies 
In describing the health system framework component on medicines and related medical 
products, WHO stated that a well-functioning health system ensures equitable access to 
essential medical products, vaccines and technologies of assured quality, safety, efficacy and 
cost-effectiveness, and their scientifically sound and cost-effective use (WHO 2007; WHO 2010). 
This study showed that medicines, equipment, and supplies were inadequate at health facilities. 
This was a gap highlighted by health system stakeholders, health service providers, and the 
HFA. Although poor funding was a major issue relating to the availability of supplies, lack of a 
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system for monitoring/maintaining materials, equipment, and supplies in most of the facilities was 
another key issue. Service delivery is difficult when equipment and commodities are not 
available. This challenge is not specific to FGM/C as it mirrors the state of the health system in 
the country. The poor state of the health system has been documented (Uneke et al. 2007; Efe 
2013). Another reason that could explain unavailability of necessary commodities could be the 
concentration of health care in urban settings and its neglect in the rural areas. Most of the health 
facilities assessed in this study were concentrated in the rural areas of Imo State. It has been 
established that most facilities located in rural areas do not function properly (Ajilowo and Olujimi 
2007). Unavailability of necessary materials at facilities as found in this study contributes 
significantly to the challenges that health workers face in service delivery (Chankova et al. 2007).  
Limitations 
Study findings should be interpreted in light of the following limitations. First, a major limitation of 
this study was that most health facilities were selected from within the pre-selected 10 UNJP 
intervention local government areas in Imo State. Only six facilities were assessed outside these 
10 LGAs bringing the representation of LGAs to 14, which is just over half of the LGAs in Imo 
State. As a result, study findings cannot be generalised to all facilities in Imo State and other 
states given marked differences in contexts, social norms, governance, and availability of health 
system–related resources. Second, it was difficult to recruit the desired number of patients and 
their families because of the hidden nature of the practice making it difficult to fully explore issues 
around satisfaction and quality of care from a limited number of clients. Nonetheless, results 
shed light on the pattern of complications seen in Imo State and the response in terms of 
management and prevention of the practice.  
Conclusion  
Findings from this study highlighted key gaps that have serious implications for the health system 
and its function in addressing FGM/C. The ineffective implementation of policies is attributable to 
the low priority placed on FGM/C. It was shown in this study that funding constitutes the most 
significant barrier to FGM/C related prevention and management activities. Findings also 
revealed that coupled with the shortage of manpower at assessed facilities, there was lack of 
knowledge for FGM/C–specific prevention and management. Additionally, issues of FGM/C were 
not documented at the health facility and, as a result, data were almost nonexistent; and 
medicines, equipment, and supplies were inadequate at health facilities. While it was recorded 
that in Imo State, there has been use of sensitisation, outreach, and visitations, and integration of 
FGM/C topics into antenatal care at PHCs, the health system's response to prevention and 
management of complications was suboptimal. Overall, the findings from this study suggest 
improving the health system response in the prevention and management of FGM/C 
complications requires government ownership at all tiers.  
Implications for Policy/Programmes/Research 
Programmatic implications 
• While multisectoral collaboration was a useful strategy in reviewing the NPPA for the 
elimination of FGM/C at the national level, several state stakeholders who statutorily should 
be on the FGM/C technical committees were unaware and not knowledgeable about the 
policy or its content. This reflects poor dissemination of policies and engagement of state 
stakeholders and has implications for stakeholders’ participation in the implementation 
process. Efforts to ensure widespread dissemination of policy documents to all actors 
involved in the FGM/C response are warranted. 
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• The ownership and coordination role of the government in the FGM/C response is 
discouraging because of poor financial commitment on its part and over-reliance on donor 
funding. This may threaten the sustainability of FGM/C programmes and reverse gains 
achieved. The government should demonstrate more financial commitment and ensure 
transition and ownership of activities beyond the tenure of FGM/C projects.  
• As a result of poor reporting of FGM/C cases at the secondary and tertiary facilities, health 
workers and critical stakeholders perceive that FGM/C was not a public health concern that 
should receive government priority and attention. This issue must be addressed though 
education of health service providers and improved data management systems.  
• Health workers should be properly trained and sensitised on the WHO guidelines on the 
management of FGM/C complications to improve their capacity to respond to incidents.  
Policy implications 
• Even though the VAPP Act criminalises FGM/C and other traditional harmful practices, it 
does not criminalise failure to report cases. This might be responsible for the gross 
underreporting of FGM/C cases as evidenced in this study. The policy should be 
strengthened to provide incentives for reporting or punishments for failure to report incidents. 
• Multisectoral involvement of stakeholders at the national and state levels in the policy 
formulation process is critical to ensure that all contextual issues that could act as barriers to 
policy implementation are addressed. 
Research implications 
▪ Given the context in which VAPP was repealed in Imo State, it is possible that similar 
reasons might be related to the non-domestication of the Act in other states. Research to 
explore stakeholders’ perceptions about the issues affecting the domestication and 
implementation of VAPP Sct in Nigeria would be invaluable.  
▪ Only a few clients were interviewed for client satisfaction in this study because of the difficulty 
in recruitment because of the short timeframe for the research activity. Research should be 
commissioned to explore client satisfaction, quality of care and management of FGM/C 
complications.  
 42 
 
References 
28TooMany. 2016. “Country Profile: FGM in Nigeria.” Available at: 
http://www.28toomany.org/countries/Nigeria/ 
Abimbola, S., T. Olanipekun, M. Schaaf, J. Negin, S. Jan, and A.L. Martiniuk. 2017. “Where there 
is no policy: Governing the posting and transfer of primary health care workers in 
Nigeria,” The International Journal of Health Planning and Management 32(4): 492–508. 
Adekanle, A.D., A.I. Isawumi, and A.S. Adeyemi. 2011. “Health workers' knowledge of and 
experience with female genital cutting in Southwestern Nigeria,” Sierra Leone Journal of 
Biomedical Research 3(2): 84–87. 
Ajilowo, O.B. and B. Olujimi. 2007. “Accessibility of the rural dwellers to healthcare facilities in 
Nigeria: The Owo experience,” Pakistan Journal of Social Science 4(1): 44–55. 
Awusi, V.O. 2009. “Tradition versus female circumcision: A study of female circumcision among 
the Isoko tribe of Delta State of Nigeria,” Benin Journal of Postgraduate Medicine 11(1). 
Behrendt, A. and S. Moritz. 2005. “Posttraumatic stress disorder and memory problems after 
female genital mutilation,” American Journal of Psychiatry 162: 1000−1002. 
Berg, R.C., V. Underland, J. Odgaard-Jensen, A. Fretheim, and G.E. Vist. 2014. “Effects of 
female genital cutting on physical health outcomes: A systematic review and meta-
analysis,” BMJ Open 4(11): e006316. 
BudgIT. 2018. “Nigeria: Health Budget Analysis.” Policy Brief. Available at: 
http://yourbudgit.com/wp-content/uploads/2018/04/Nigeria-Health-Budget-Analysis.pdf  
Central Intelligence Agency (CIA). 2018. “World Fact Book.” Available at: 
https://www.cia.gov/library/publications/the-world-factbook/geos/ni.html 
Chankova, S., H. Nguyen, D. Chipanta, G. Kombe, A. Onoja, and K. Ogungbemi. 2007. 
“Catalyzing human resources mobilization: A look at the situation in Nigeria.” Global 
Health Council Annual Conference, Washington, DC, May. 
Chen, L.C. and J.I. Boufford. 2005. “Fatal flows—doctors on the move,” New England Journal of 
Medicine 353(17): 1850-1852.  
Chibber, R., E. El-Saleh, and J. El Harmi. 2011. “Female circumcision: Obstetrical and 
psychological sequelae continues unabated in the 21st century,” Journal of Maternal-
Fetal & Neonatal Medicine 24: 833–836. 
Dare, F.O., V.O. Oboro, S.O. Fadiora, E.O Orji, A.O. Sule-Odu, and T.O. Olabode. 2004. 
“Female genital mutilation: An analysis of 522 cases in South-Western Nigeria,” Journal 
of Obstetrics and Gynaecology 24(3): 281–283. 
Efe, S.I. 2013. “Health care problem and management in Nigeria,” Academic Journals 6(6): 244–
254. 
Elnashar, A. and R. Abdelhady. 2007. “The impact of female genital cutting on health of newly 
married women,” International Journal of Gynecology & Obstetrics 97(3): 238–244. 
Federal Ministry of Health (FMOH). 2010. National Strategic Health Development Plan (NSHDP) 
2010-2015. Abuja: FMOH. 
___. 2013. National Policy and Plan of Action for the Elimination of Female Genital Mutilation in 
Nigeria. Abuja: FMOH. 
___. 2016. National Health Policy. Abuja: FMOH. 
 43 
 
Gyuse, A.N., A.E. Ayuk, and M.C. Okeke. 2018. “Facilitators and barriers to effective primary 
health care in Nigeria,” African Journal of Primary Health Care and Family Medicine 
10(1): 1641. 
Ichoku, H. and C.I. Okoli. 2015. “Fiscal space for health financing in Nigeria,” African Journal of 
Health Economics. E-publication ahead of print. 
Ike, S.O. 2007. “The health workforce crisis: The brain drain scourge,” Nigerian Journal of 
Medicine 16: 204–11. 
Kaplan, A., S. Hechavarría, M. Martín, and I. Bonhoure. 2011. “Health consequences of female 
genital mutilation/cutting in the Gambia, evidence into action,” Reproductive Health 8: 26. 
Kimani, S, J. Muteshi, and C. Njue. 2016. “Health Impacts of FGM/C: A Synthesis of the 
Evidence,” Evidence to End FGM/C Programme: Research to Help Girls and Women 
Thrive. New York: Population Council.  
Kimani, S., T. Esho, V. Kimani, S. Munju, J. Kamau, C. Kigondu, J. Karanja, and J. Guyo. 2018. 
“Female genital mutilation/cutting: Innovative training approach for nurse-midwives in 
high prevalent settings,” Obstetrics and Gynecology International 15 Mar: 5043512. 
Knight, R., A. Hotchin, C. Bayly, and S. Grover. 1999. “Female genital mutilation: Experience of 
the Royal Women's Hospital, Melbourne,” Australian and New Zealand Journal of 
Obstetrics and Gynaecology 391: 50–54  
Lazarus, J.V. and T. France. 2014. “A New Era for the WHO Health System Building Blocks?” 
Commentary. Health Systems Global. https://www.healthsystemsglobal.org/blog/9/A-
new-era-for-the-WHO-health-system-building-blocks-.html 
 
Mbanya, V.N., A.A. Gele, E. Diaz, and B. Kumar. 2018. “Health care-seeking patterns for female 
genital mutilation/cutting among young Somalis in Norway,” BMC Public Health 18: 517. 
Miller, R., A. Fisher, K. Miller, L. Ndhlovu, B.N. Maggwa, I. Askew, D. Sanogo, and P. 
Tapsoba. 1997. The Situation Analysis Approach to Assessing Family Planning and 
Reproductive Health Services. A Handbook. New York: Population Council.  
Morison, L., C. Scherf, G. Ekpo, K. Paine, B. West, R. Coleman, and G. Walraven. 2001. “The 
long-term reproductive health consequences of female genital cutting in rural Gambia: A 
community-based survey,” Tropical Medicine & International Health 6(8): 643–653. 
National Bureau of Statistics (NBS) and United Nations Children’s Fund (UNICEF). 2017. 
Multiple Indicator Cluster Survey 2016-17, Survey Findings Report. Abuja: NBS and 
UNICEF. 
___. 2018. National Nutrition and Health Survey (NNHS): Report on the nutrition  
and health situation of Nigeria, 2018. Abuja: NBS and UNICEF. Available at: 
https://www.unicef.org/nigeria/media/2181/file/Nigeria-NNHS-2018.pdf 
 
National Population Commission (NPC) [Nigeria] and ICF International. 2014. Nigeria 
Demographic and Health Survey 2013. Abuja and Rockville, MD: NPC and ICF 
International. 
___. 2019. Nigeria Demographic and Health Survey 2018. Abuja, and Rockville, MD: NPC and 
ICF. 
National Primary Health Care Development Agency (NPHCDA). 2015. Minimum Standards for 
Primary Health Care in Nigeria. Abuja: Federal Government of Nigeria.  
 44 
 
Nigeria National Health Conference (NHC). 2009. Communique. Abuja: NHC. Available at: 
http://www.ngnhc.org 
Njue, C. and I. Askew. 2004. “Medicalization of Female Genital Cutting Among the Abagusii in 
Nyanza Province, Kenya.” Frontiers in Reproductive Health Program. Washington, DC: 
Population Council. Available at 
http://www.popcouncil.org/uploads/pdfs/poster/frontiers/FR_FinalReports/Kenya_FGC_M
ed.pdf 
Ofor, M.O. and N.M. Ofole. 2015. “Female genital mutilation: The place of culture and the 
debilitating effects on the dignity of the female gender,” European Scientific Journal 
11(14): 112–121. 
Omoleke, I.I. and B.A. Taleat. 2017. “Contemporary issues and challenges of health sector in 
Nigeria, Research Journal of Health Sciences  5(4): 210–216. 
 
Onyemelukwe, Cheluchi. 2016. “Legislating on violence against women: A critical analysis of 
Nigeria's recent Violence Against Persons (Prohibition) Act, 2015,” DePaul Journal of 
Women, Gender and the Law 5: 1–56.  
Oyibocha, E.O., O. Irinoye, E.O Sagua, O.T. Ogungide-Essien, J.E. Edeki, and O.L. Okome. 
2014. “Sustainable healthcare system in Nigeria: Vision, strategies and challenges,” 
IOSR Journal of Economics and Finance 5(2): 28–39. 
Rigoli, F. and G. Dussault. 2003. “The interface between health sector reform and human 
resources in health,” Human Resources for Health 1(1): 9.  
Rymer, J. 2003. “Female genital mutilation,” Current Obstetrics and Gynecology 13(3): 185–190. 
Sambo, M.N., I. Lewis, and K. Sabitu. 2005. “Quality of record system in primary health centres 
of Tafa LGA, North Central Nigeria,” Annals of Nigerian Medicine 1(1): 15–18. 
UNAIDS, UNDP, UNFPA, UNICEF, UNHCR, UNIFEM, WHO, FIGO, ICN, IOM, WCPT, WMA, and 
MWIA. 2010. Global Strategy to Stop Health-Care Providers from Performing Female 
Genital Mutilation. Geneva: WHO. Available at: 
https://apps.who.int/iris/bitstream/handle/10665/70264/WHO_RHR_10.9_eng.pdf;jsessio
nid=21263D4EE132E54C189D6E9F79E5E6CF?sequence=1 
Uneke, C.J., A. Ogbonna, A. Ezeoha, P.G. Oyibo, F. Onwe, and B. Ngwu, and Innovative Health 
Research Group. 2007. “The Nigeria health sector and human resource challenges,” The 
Internet Journal of Health 8(1). 
UNFPA-UNICEF. 2019. “UNFPA-UNICEF Joint Programme to Eliminate Female Genital 
Mutilation.” New York: United Nations Population Fund. Available at: 
www.unfpa.org/unfpa-unicef-joint-programme-eliminate-female-genital-mutilation. 
UNICEF. 2014. Female Genital Mutilation/Cutting: What Might the Future Hold? New York: 
UNICEF. 
___. 2016. “Female Genital Mutilation/ Cutting: A Global Concern.” Brochure. New York: 
UNICEF. Available at: www.data.unicef.org/resources/female-genital-mutilation-cutting-a-
global-concern.html  
UNICEF and G.R. Gupta. 2013. “Female genital mutilation/cutting: A statistical overview and 
exploration of the dynamics of change,” Reproductive Health Matters 184-190. 
 45 
 
Vloeberghs, E., A. van der Kwaak, J. Knipscheer, and M. van den Muijssenbergh. 2012. “Coping 
and chronic psychosocial consequences of female genital mutilation in The Netherlands,” 
Ethnicity & Health 17(6): 677–195. 
Walt, G. and L. Gilson. 1994. ‘Reforming the health sector in developing countries: The central 
role of policy analysis,” Health Policy and Planning 9(4): 353–370. 
Whitehorn, K., O. Ayorinde, and S. Maingay. 2002. “Female genital mutilation: Cultural and 
psychological implications,” Sexual and Relationship Therapy 17(2): 161–170. 
World Bank. 2019. “Gender-Based Violence: An Analysis of the Implications for the Nigeria for 
Women Project.” Working Paper. Washington, DC: World Bank. Available at: 
http://documents.worldbank.org/curated/en/731521555064925144/Gender-Based-
Violence-An-Analysis-of-the-Implications-for-the-Nigeria-for-Women-Project. 
World Health Organization (WHO). 2000. “A Systematic Review of the Health Complications of 
Female Genital Mutilation Including Sequelae in Childbirth.” Geneva: WHO. Available at: 
http://whqlibdoc.who.int/hq/2000/WHO_FCH_WMH_00.2.pdf 
___. 2007. Everybody’s Business: Strengthening Health Systems to Improve Health Outcomes.  
WHO’s Framework for Action. Geneva: WHO. 
 
___. 2008. “Eliminating Female Genital Mutilation: An Interagency Statement.: Geneva: WHO. 
Available at: 
http://www.unfpa.org/webdav/site/global/shared/documents/publications/2008/eliminating
_fgm.pdf. 
___. 2015. Health in 2015: From MDGs to SDGs. Geneva: WHO, p. 17. 
___. 2016a. “Nigeria,” Global Health Workforce Alliance. Geneva: WHO. Available at: 
https://www.who.int/workforcealliance/countries/nga/en/ 
___. 2016b. WHO Guidelines on the Management of Health Complications from Female Genital 
Mutilation (No. 9789241549646). Geneva” WHO. 
WHO Sudy Group on Female Genital Mutilation and Obstetric Outcome, E. Banks, O. Meirik, T. 
Farley, O. Akande, H. Bathija, and M. Ali. 2006. “Female genital mutilation and obstetric 
outcome: WHO collaborative prospective study in six African countries,” Lancet 
367(9525): 1835–1841. 
Willis-Shattuck, M, P. Bidwell, S Thomas, L. Wyness, D. Blaauw, and P. Ditlopo. 2008. 
“Motivation and retention of health workers in developing countries: A systematic review,” 
BMC Health Services Research 8(4): 247.  
Yoder, P.S., S. Wang, and E. Johansen. 2013. “Estimates of female genital mutilation/cutting in 
27 African countries and Yemen,” Studies in Family Planning 44(2): 189–204. 
 
 
 46 
 
 
Appendix 1: List of Study Contributors 
Government  
Federal/National level 
Chris Ugboko (Federal Ministry of Health) 
 
Imo State  
Dr. A. C. Okeji (State Ministry of Health) 
Ms. Ejionye Thecla (State Ministry of Health) 
Ezeka Julie Ngozi (State Ministry of Gender Affairs) 
Dr. G. N. Nwambara (State Hospital Management Board) 
Dr. Victoria Dike (Imo State Primary Health Care Development Agency) 
 
Imo State University Teaching Hospital (IMSUTH) 
Dr.  Federick Anolue  
Dr. Ephraim Dike  
  
Consultants for Clinical Grand Round 
Reverend Sister Dr. Maria-Joannes Uzoma (IMSUTH) 
Dr. Aigbe Ohihoin (Nigerian Institute of Medical Research) 
 
Data Collectors  
Ogbozor Pamela Adaobi  
Nwankwo O. Perpetual 
Chibundu O. Nelson  
Desmond Denis 
Okoroafor Ikenna Emmanuel  
Nwaeze Miriam Adaeze 
Ekwueme Prince 
Ekwugha Uche Onyx 
Onyeneke Christabel 
Ikepeazu Chineye 
Agbarakwu Deborah 
Amaechi Glory 
Uba Eucharia 
 
Study Participant Recruitment  
Dr. G. N. Nwambara (State Hospital Management Board) 
Egesionu Adanna (Imo State Primary Health Care Development Agency) 
Benjamin Mbakwem (Community and Youth Development Initiatives - CYDI)  
Ekeh Faustina (National Association of Community Health Practitioners of Nigeria) 
Ms. Achunine Stella M (National Association of Nigerian Nurses and Midwives) 
Mr. Onah Ikedi L. (National Association of Nigerian Nurses and Midwives) 
 
 
